Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Proteoglycan biosynthesis WP4784,0.0012960901422964552,5.263012987012987,34.990632012033934,"['EXT1', 'EXT2', 'CHSY1', 'B3GAT3', 'IMPAD1', 'XYLT1', 'B3GALT6', 'EXTL3', 'PAPSS2']",0.5234730791958174,0,0,9
2,Mesodermal commitment pathway WP2857,0.0019316349785823523,1.9610637680683491,12.255449351154036,"['SETD2', 'CTBP2', 'NCAPG2', 'CHRD', 'HTT', 'PHF6', 'MBTD1', 'PPP2CA', 'EPB41L5', 'C1QBP', 'UBR5', 'CEP250', 'DIP2A', 'PRKACA', 'KDM6A', 'ACVR1', 'SMAD2', 'ATP8B2', 'AXIN2', 'TRERF1', 'EMSY', 'ADAM19', 'EXT1', 'LATS1', 'EXT2', 'MEIS1', 'BHLHE40', 'MTF2', 'WDFY2', 'BMPR1A', 'NFE2L2', 'CUL4B']",0.5234730791958174,0,0,32
3,Autophagy WP4923,0.006005957245618067,2.8900832994282535,14.782785983948827,"['RPTOR', 'BECN1', 'PRKAA1', 'MAP1LC3B', 'DEPTOR', 'AKT1S1', 'PIK3R4', 'PIK3C3', 'AMBRA1', 'ATG7', 'ATG13', 'ATG5']",0.7694695691506297,0,0,12
4,Alzheimer's disease WP2059,0.009075347448637413,1.9602230306111101,9.21734821501239,"['BAD', 'ITPR1', 'ATP2A2', 'ADAM10', 'ATP2A1', 'PSEN1', 'GRIN2D', 'APH1A', 'VMP1', 'NCSTN', 'GRIN2A', 'PPP3CC', 'CDK5', 'CAPN2', 'NOS1', 'APBB1', 'PLCB1', 'ATF6', 'PLCB2', 'GAPDH', 'MAPK3', 'CDK5R1']",0.7694695691506297,0,0,22
5,Computational Model of Aerobic Glycolysis WP4629,0.01070779860494226,4.907664366146022,22.26500807663521,"['LDHA', 'PKM', 'SLC2A1', 'ENO1', 'GAPDH', 'PFKM']",0.7694695691506297,0,0,6
6,Glycolysis in senescence WP5049,0.01070779860494226,4.907664366146022,22.26500807663521,"['RB1', 'LDHA', 'PRKAA1', 'PKM', 'ENO1', 'GAPDH']",0.7694695691506297,0,0,6
7,Ectoderm Differentiation WP2858,0.015077291333618407,1.650974025974026,6.925118777129793,"['NLGN1', 'STX16', 'CTNND2', 'ARHGDIG', 'LDB2', 'JAKMIP1', 'CELSR2', 'CDH8', 'WDR44', 'PHF8', 'CDH6', 'TRPM2', 'SDCBP', 'PLXNA2', 'UBTF', 'FYN', 'CTNNA2', 'CLVS1', 'BCAS3', 'KCNK10', 'SMURF1', 'C1GALT1', 'SERPINB6', 'PPFIBP2', 'ZNF219', 'ROR2', 'KIFC3', 'PDE7A', 'TRIM33', 'ASTN1', 'BMPR1A']",0.7694695691506297,0,0,31
8,Fragile X Syndrome  WP4549,0.01619805343491361,1.6112042762813121,6.642776433276214,"['CYFIP2', 'SH3GL3', 'ABCD3', 'CLTC', 'TECR', 'ITPR1', 'CLTB', 'GPHN', 'RPTOR', 'GRIN2A', 'GRM5', 'DEPTOR', 'FYN', 'PRKACA', 'EIF4E', 'GABRD', 'EPHA4', 'GABRA1', 'NTRK2', 'CPT1A', 'MAP2K1', 'DICER1', 'AP2B1', 'DNM2', 'ALDH3A2', 'DLG4', 'TBC1D7', 'AKT1S1', 'NF1', 'KRAS', 'PLCB1', 'EIF4G1', 'HCN1']",0.7694695691506297,0,0,33
9,Pathways in clear cell renal cell carcinoma WP4018,0.01821252937652152,1.802762148337596,7.221226077099187,"['SETD2', 'TGFB2', 'BHLHE41', 'SLC2A1', 'ARNT', 'ENO1', 'ENO2', 'SDSL', 'RPTOR', 'ACLY', 'LDHB', 'TOX2', 'LDHA', 'DEPTOR', 'PKM', 'AKT1S1', 'EP300', 'CEP290', 'GAPDH', 'PFKM', 'PSPH', 'BAP1']",0.7694695691506297,0,0,22
10,Thiamine metabolic pathways WP4297,0.018237136811141173,5.110748002904866,20.464944103926154,"['PDHA1', 'TPK1', 'SLC19A3', 'TKT', 'SLC19A2']",0.7694695691506297,0,0,5
11,Pathways affected in adenoid cystic carcinoma WP3651,0.022135122490216028,1.9336656130966854,7.368406227968286,"['MAGI1', 'SETD2', 'BRD1', 'CNTN6', 'KMT2C', 'MGA', 'JMJD1C', 'ARID4B', 'MORF4L1', 'KANSL1', 'KAT6A', 'NSD1', 'CHEK1', 'EP300', 'TLK1', 'ATM', 'KDM6A']",0.7694695691506297,0,0,17
12,Glycolysis and Gluconeogenesis WP534,0.02272893641703887,2.3690913966138054,8.964917688161165,"['LDHB', 'LDHA', 'PDHA1', 'PKM', 'PGAM1', 'GOT2', 'SLC2A1', 'ENO1', 'ENO2', 'PFKM', 'GAPDH']",0.7694695691506297,0,0,11
13,MTHFR deficiency WP4288,0.024645844067783803,2.6298701298701297,9.738795656475306,"['GRIN2A', 'PCYT1A', 'SGMS1', 'NDUFAF7', 'MARS', 'DNMT3A', 'EHMT1', 'CHPT1', 'GRIN2D']",0.7694695691506297,0,0,9
14,Interleukin-11 Signaling Pathway WP2332,0.025245541349962992,2.1282884195193006,7.830198096046394,"['ATF1', 'MAP2K1', 'CHUK', 'PDPK1', 'IL11RA', 'TYK2', 'RUNX2', 'IKBKB', 'PTPA', 'BGLAP', 'FYN', 'JAK1', 'MAPK3']",0.7694695691506297,0,0,13
15,ATM Signaling Network in Development and Disease  WP3878,0.025940485245706434,2.0466302367941713,7.474192099230902,"['HDAC4', 'PRKAA1', 'ATMIN', 'H2AFX', 'RNF40', 'PTPA', 'RNF168', 'CDK5', 'CHEK1', 'ATM', 'CEP63', 'LBR', 'CDK5R1', 'ATR']",0.7694695691506297,0,0,14
16,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.025940485245706434,2.0466302367941713,7.474192099230902,"['BECN1', 'PRKAA1', 'PIK3R4', 'ATG13', 'RPTOR', 'DCAF17', 'DEPTOR', 'SCP2', 'AKT1S1', 'PIK3C3', 'ATG4A', 'ATG7', 'ATG5', 'FTL']",0.7694695691506297,0,0,14
17,Sulindac Metabolic Pathway WP2542,0.025950070792692324,12.260159651669087,44.76896532172078,"['MSRA', 'MSRB2', 'MSRB3']",0.7694695691506297,0,0,3
18,CAMKK2  Pathway WP4874,0.029129749433571942,2.2504366812227072,7.957533549603436,"['HDAC4', 'RPTOR', 'CHRM3', 'STIM1', 'EP300', 'NFATC2', 'NOS1', 'ARHGEF7', 'GIT1', 'MAPK3', 'NFE2L2']",0.7694695691506297,0,0,11
19,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.03064262590712605,4.088235294117647,14.24898499363124,"['GRM3', 'GRM2', 'GRM5', 'GRM4', 'GRM7']",0.7694695691506297,0,0,5
20,Endoderm differentiation WP2853,0.03136516959979602,1.5717460110451789,5.441474672938681,"['CTBP2', 'NCAPG2', 'PHF6', 'CDC73', 'MBTD1', 'EPB41L5', 'BTAF1', 'CAND1', 'C1QBP', 'UBR5', 'CEP250', 'DIP2A', 'BPTF', 'SMAD2', 'ATP8B2', 'CDYL', 'FOXN3', 'TRERF1', 'EMSY', 'EXT1', 'MAD2L2', 'TNRC6C', 'MTF2', 'WDFY2', 'NAA15', 'EZH2', 'BMPR1A', 'CUL4B']",0.7694695691506297,0,0,28
21,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.03461701839486376,2.8625726744186046,9.628005148714749,"['SMAD2', 'NR2C2', 'MAPK14', 'TGFBR1', 'RUNX2', 'MAPK3', 'FBN1']",0.7694695691506297,0,0,7
22,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.03512891562444862,2.272745644880967,7.610813070414473,"['HDAC4', 'PPP3CC', 'NFATC3', 'EP300', 'NFATC2', 'NELFB', 'HDAC8', 'SUPT5H', 'HDAC9', 'HDAC7']",0.7694695691506297,0,0,10
23,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.03539856115953353,1.5124458874458875,5.053208914035619,"['PRKAA1', 'THRB', 'MAPKAP1', 'PIK3R4', 'SLC2A1', 'CBLB', 'PIK3C2A', 'RPTOR', 'RPS6KA3', 'GYS1', 'RPS6KA6', 'RPS6KA5', 'SESN3', 'MAP3K9', 'MAP3K7', 'EIF4E', 'MAP3K4', 'MAP2K5', 'MAPK3', 'MAP4K4', 'MAP3K2', 'MAP3K3', 'PTPN1', 'MAP2K1', 'MAP3K1', 'PDPK1', 'MAPK14', 'MLXIPL', 'RAPGEF1', 'PIK3C3', 'MAP3K13']",0.7694695691506297,0,0,31
24,Glycogen Synthesis and Degradation WP500,0.037696834517444454,2.045868219876229,6.7067225484043425,"['PPP2CA', 'PTPA', 'GYS1', 'PPP2R1B', 'PPP2R1A', 'PPP2R2B', 'AGL', 'PPP2R2A', 'PPP2R5D', 'PPP2R3A', 'PPP2R5C', 'GYG2']",0.7694695691506297,0,0,12
25,Cardiac Hypertrophic Response WP2795,0.038186815578182945,1.8604227405247813,6.07477319449635,"['HDAC4', 'MAP2K1', 'MAP3K1', 'CHUK', 'PDPK1', 'NFATC2', 'MAPK14', 'HDAC9', 'TGFBR1', 'HDAC7', 'IKBKB', 'PRKD1', 'MAP3K7', 'MAP2K5', 'MAPK3']",0.7694695691506297,0,0,15
26,Histone Modifications WP2369,0.03819627133678207,1.9702867470529524,6.433020467034048,"['KMT2E', 'SETD2', 'KMT2A', 'SETDB1', 'SETD6', 'KMT2C', 'SETD7', 'SETDB2', 'EHMT1', 'SETBP1', 'NSD1', 'SMYD2', 'EZH2']",0.7694695691506297,0,0,13
27,Synaptic Vesicle Pathway WP2267,0.03833150990233764,1.9098482088646023,6.2289374814215615,"['UNC13B', 'NSF', 'UNC13C', 'SYT1', 'CLTC', 'CACNA1B', 'CACNA1A', 'AP2B1', 'SYN3', 'SYN2', 'DNM2', 'DNM3', 'SLC17A7', 'STX2']",0.7694695691506297,0,0,14
28,16p11.2 proximal deletion syndrome WP4949,0.04168253822174608,1.6910663281497937,5.373655787746034,"['UNC13B', 'CCT2', 'PAXIP1', 'IGFBP3', 'KMT2C', 'PPP4R3A', 'PPP2R5D', 'PPP2CA', 'CCT6A', 'PPP4R1', 'PPP4C', 'PPP2R1A', 'PPP4R4', 'TCP1', 'CCT8', 'CCT5', 'YPEL3', 'MAPK3', 'BPTF']",0.7880117467410435,0,0,19
29,Regulation of Actin Cytoskeleton WP51,0.042162990139280924,1.4734057675430465,4.6651156904844875,"['CYFIP2', 'CHRM3', 'CHRM1', 'ROCK1', 'CHRM5', 'PIK3R4', 'IQGAP1', 'PIK3C2A', 'ACTB', 'FGD1', 'PIK3C2B', 'FGF5', 'FGF9', 'CFL2', 'PIP4K2A', 'PAK6', 'PIP4K2B', 'PIP4K2C', 'PAK2', 'GIT1', 'MAPK3', 'APC2', 'MAP2K1', 'LIMK1', 'RRAS2', 'SSH2', 'BAIAP2', 'SSH1', 'PIK3C3', 'KRAS', 'ARHGEF7', 'VCL']",0.7880117467410435,0,0,32
30,Pathogenic Escherichia coli infection WP2272,0.04618338547824889,1.8997502861304756,5.8419889138859045,"['ROCK1', 'TUBB', 'ARPC1A', 'TUBB4B', 'TUBB4A', 'ACTB', 'TUBA4A', 'TUBA1B', 'CTTN', 'TUBB3', 'ABL1', 'FYN', 'NCK1']",0.8074643525551903,0,0,13
31,Splicing factor NOVA regulated synaptic proteins WP4148,0.04618338547824889,1.8997502861304756,5.8419889138859045,"['CADM3', 'CASK', 'GRIK2', 'ATP2B1', 'ANK3', 'GPHN', 'EPB41L3', 'KCNMA1', 'TERF2IP', 'NCDN', 'STX2', 'CAMK2G', 'CLASP1']",0.8074643525551903,0,0,13
32,Phosphoinositides metabolism WP4971,0.054447126902214954,1.7901639344262295,5.210317237540986,"['MTMR1', 'PIK3R4', 'MTMR9', 'PIK3C2A', 'PIK3C2B', 'PIP4P1', 'PIP4K2A', 'PIP4K2B', 'PIK3C3', 'PIP4K2C', 'PLCH2', 'PLCB1', 'PLCB2', 'PLCD4']",0.890009007694005,0,0,14
33,Ciliary landscape WP4352,0.05569429570895959,1.3298373991845036,3.840407567946007,"['RB1', 'TTC26', 'POM121', 'PSMD12', 'CTBP2', 'GDI1', 'ZMYND19', 'TRAF3IP1', 'IFT172', 'VPS4A', 'HTRA2', 'IQGAP1', 'EHBP1', 'IFT52', 'RMND5A', 'APMAP', 'NEFL', 'TMED1', 'NINL', 'BBS5', 'CEP290', 'IQCB1', 'ZYG11B', 'CNOT6L', 'RNGTT', 'NUP133', 'IFT140', 'RHBDD2', 'IFT80', 'ARMC8', 'ARFGAP3', 'COPS3', 'EHD3', 'RABEP2', 'WDR60', 'VAPB', 'COPS2', 'GID8', 'EXOC4', 'ERF', 'MCM3', 'CD2BP2', 'ANKS6', 'DYNLRB1', 'YPEL5', 'IFT46', 'EXOC2', 'EXOC1']",0.890009007694005,0,0,48
34,NO/cGMP/PKG mediated Neuroprotection WP4008,0.055830823360878544,1.956379343079552,5.644994028266739,"['GRIN2A', 'GUCY1A1', 'GUCY1B1', 'BAD', 'DLG4', 'AKAP9', 'NEFL', 'PRKG2', 'NOS1', 'CAMK2G', 'GRIN2D']",0.890009007694005,0,0,11
35,Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex WP3657,0.06254830105864628,2.3850532945736433,6.610929368755883,"['FLT3', 'DNMT3A', 'EP300', 'ATM', 'TERF2', 'ETV6', 'MCL1']",0.9248464741446769,0,0,7
36,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.06254830105864628,2.3850532945736433,6.610929368755883,"['BECN1', 'PIK3R4', 'PIK3C3', 'ATG4A', 'ATG13', 'ATG7', 'ATG5']",0.9248464741446769,0,0,7
37,G Protein Signaling Pathways WP35,0.0634325805205648,1.5265383972306683,4.209853490842767,"['GNAZ', 'PDE1C', 'PDE1A', 'ITPR1', 'GNAI3', 'ADCY5', 'GNAI2', 'GNG13', 'AKAP12', 'AKAP13', 'PPP3CC', 'AKAP11', 'PRKAR1B', 'PRKAR2A', 'AKAP9', 'GNAS', 'KRAS', 'PRKD1', 'PDE7B', 'PRKACA', 'PDE7A', 'PDE8A']",0.9248464741446769,0,0,22
38,Circadian rhythm related genes WP3594,0.06547789743579094,1.3657849620377174,3.7231880395104513,"['KDM5A', 'NLGN1', 'PRKAA1', 'PHLPP1', 'AHCY', 'CHRM1', 'KMT2A', 'CIPC', 'BHLHE41', 'CREM', 'CCAR2', 'ARNTL2', 'ARNTL', 'PPP1CC', 'DBP', 'NAGLU', 'EP300', 'PRKG2', 'BTRC', 'CPT1A', 'JUND', 'KCNH7', 'NONO', 'GFPT1', 'ARNT', 'NR1D1', 'BTBD9', 'NR2F6', 'MYBBP1A', 'PSPC1', 'KCNMA1', 'BHLHE40', 'FBXL3', 'TOP1', 'PPARA', 'LGR4', 'EZH2']",0.9248464741446769,0,0,37
39,miRNAs involved in DNA damage response WP1545,0.06822932621326931,2.9196493412179687,7.838910468984498,"['RAD52', 'CDK6', 'H2AFX', 'ABL1', 'ATM']",0.9248464741446769,0,0,5
40,NRF2 pathway WP2884,0.0682543523354005,1.4946103685138772,4.012302573110917,"['GSTM3', 'CBR1', 'TGFB2', 'HSP90AA1', 'GPX3', 'SLC2A13', 'GSTP1', 'SLC2A1', 'SLC39A11', 'KEAP1', 'SLC2A6', 'SLC2A8', 'SLC2A9', 'SLC6A6', 'DNAJB1', 'SLC5A8', 'GCLC', 'FTH1', 'SLC39A6', 'SLC39A7', 'SLC39A1', 'FTL', 'NFE2L2']",0.9248464741446769,0,0,23
41,3q29 copy number variation syndrome WP4906,0.0723762129993583,1.6587049877866205,4.355556244749019,"['DYNC2H1', 'PCYT1A', 'TFRC', 'MYCBP2', 'ADAM10', 'MAD2L1BP', 'RNF168', 'DLG1', 'TF', 'BRINP1', 'WDR60', 'UBXN7', 'FGFR1OP', 'DYNLRB1', 'PAK2']",0.9443864663485322,0,0,15
42,Calcium Regulation in the Cardiac Cell WP536,0.07506796762905277,1.3961157933308905,3.615048262496231,"['CHRM3', 'GNAZ', 'RGS17', 'CHRM1', 'CHRM5', 'CACNA1B', 'ITPR1', 'GNAI3', 'CACNA1A', 'ATP2A2', 'ARRB1', 'ADCY5', 'GNAI2', 'RGS2', 'GRK4', 'PRKAR2A', 'PRKACA', 'CAMK2G', 'RGS6', 'YWHAG', 'ATP2B3', 'ATP1B3', 'ATP2B1', 'ATP1B1', 'GNG13', 'PRKAR1B', 'STIM2', 'GNAS', 'PRKD1', 'CASQ1']",0.9443864663485322,0,0,30
43,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.07684605512611739,1.7154453398491647,4.4017489295811645,"['MAP3K3', 'MAP2K1', 'MAP3K1', 'CHUK', 'MAPK14', 'IKBKB', 'RPS6KA5', 'IRAK2', 'MAPKAPK2', 'TAB2', 'MAP3K7', 'EIF4E', 'MAPK3']",0.9443864663485322,0,0,13
44,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.07885296359351025,1.7529772739091996,4.452860949878552,"['IKBKB', 'MAP2K1', 'DLG1', 'CHUK', 'AHSA1', 'NFATC2', 'LCP2', 'FYN', 'MAP3K7', 'MALT1', 'NCK1', 'MAPK3']",0.9443864663485322,0,0,12
45,Signal Transduction of S1P Receptor WP26,0.08047490837400262,2.2013919946332736,5.54708921057249,"['GNAI3', 'S1PR3', 'PLCB1', 'PLCB2', 'PIK3C2B', 'GNAI2', 'MAPK3']",0.9443864663485322,0,0,7
46,Urea cycle and associated pathways WP4595,0.08047490837400262,2.2013919946332736,5.54708921057249,"['LDHB', 'OAT', 'GOT2', 'GPT', 'NOS1', 'SLC25A12', 'SLC25A13']",0.9443864663485322,0,0,7
47,Disruption of postsynaptic signaling by CNV WP4875,0.08189329136232659,1.858857766460531,4.65149080486469,"['NLGN1', 'GRIN2A', 'DLG1', 'DLG2', 'NRXN3', 'DLGAP1', 'CAMK2G', 'YWHAG', 'MAPK3', 'GRIN2D']",0.9443864663485322,0,0,10
48,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.08779627871685765,1.5456925196531324,3.760262089244248,"['PRKN', 'PSMD12', 'PSMD14', 'TUBB', 'CASK', 'UBE2L6', 'TUBB4B', 'TUBB4A', 'TUBA4A', 'TUBA1B', 'PSMC3', 'TUBB3', 'PSMD2', 'RNF19A', 'PSMD3', 'PSMD1', 'STUB1']",0.9913663138445176,0,0,17
49,Cori Cycle WP1946,0.09350675951442476,2.554466230936819,6.05337367882598,"['LDHA', 'PGAM1', 'SLC2A1', 'GPT', 'GAPDH']",0.9999871313821947,0,0,5
50,7q11.23 copy number variation syndrome WP4932,0.09383082116469416,1.4262914230019492,3.3749790426998274,"['RB1', 'ATPAF2', 'BECN1', 'ELN', 'CLTC', 'H2AFX', 'LIMK1', 'UBE2E1', 'SMARCA5', 'DDX21', 'UBE2L6', 'VPS37A', 'MLXIPL', 'TBL2', 'MYO1C', 'MYBBP1A', 'BCL7B', 'GAPDH', 'VPS28', 'CLASP1', 'FBN1', 'CLASP2', 'MAPK3']",0.9999871313821947,0,0,23
51,Integrated Cancer Pathway WP1971,0.09516367288812577,1.73018139066174,4.069658264673334,"['ATF1', 'RB1', 'SMAD2', 'POU2F1', 'BAD', 'CHEK1', 'ATM', 'BACH1', 'JAK1', 'CDC25B', 'ATR']",0.9999871313821947,0,0,11
52,Effects of nitric oxide WP1995,0.1008765279300153,8.170475154153065,18.741909843060178,"['HBA1', 'NOS1']",0.9999871313821947,0,0,2
53,Tgif disruption of Shh signaling WP3674,0.1008765279300153,8.170475154153065,18.741909843060178,"['SMAD2', 'FOXG1']",0.9999871313821947,0,0,2
54,Resistin as a regulator of inflammation WP4481,0.10100016692376837,1.9239207133234972,4.410844327286838,"['IKBKB', 'CHUK', 'ITPR1', 'MAPK14', 'PLCB1', 'PLCB2', 'PLCD4', 'MAPK3']",0.9999871313821947,0,0,8
55,EGF/EGFR signaling pathway WP437,0.10202347900573568,1.3046386241099257,2.977905899770822,"['ATF1', 'SH3GL3', 'ROCK1', 'SH3KBP1', 'CBLB', 'ASAP1', 'IQGAP1', 'PIK3C2B', 'RPS6KA3', 'RPS6KA5', 'ABL1', 'MAP3K4', 'MAP2K5', 'NCK1', 'JAK1', 'MAP3K2', 'MAP3K3', 'MAP2K1', 'JUND', 'MAP3K1', 'PDPK1', 'TNK2', 'NCOA3', 'LIMK2', 'STAM', 'EPS15L1', 'GAB2', 'AP2B1', 'MAPK14', 'EPN1', 'VAV2', 'RASA1', 'KRAS', 'RIN1', 'STAM2', 'ARF6']",0.9999871313821947,0,0,36
56,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.1072168690474873,1.635820895522388,3.6526272294024427,"['SMAD2', 'ZEB2', 'ZFYVE9', 'EP300', 'LTBP3', 'ZNF423', 'SMAD5', 'TGFBR1', 'RUNX2', 'JAK1', 'MAPK3', 'FBN1']",0.9999871313821947,0,0,12
57,Senescence and Autophagy in Cancer WP615,0.10791394796367443,1.4356629068106557,3.1963902565028204,"['RB1', 'BECN1', 'MAP2K1', 'KMT2A', 'IGFBP3', 'AMBRA1', 'BMI1', 'MAPK14', 'ATG13', 'CDC25B', 'RSL1D1', 'MAP1LC3B', 'LAMP1', 'LAMP2', 'AKT1S1', 'FKBP8', 'PIK3C3', 'SLC39A1', 'ATG7', 'ATG5']",0.9999871313821947,0,0,20
58,Aryl Hydrocarbon Receptor Netpath WP2586,0.1112176666203421,1.6659523424443365,3.6588745494699775,"['RB1', 'HSP90AA1', 'MAP2K1', 'GCLC', 'PSRC1', 'AIP', 'NF1', 'EP300', 'ARNT', 'KRAS', 'NFE2L2']",0.9999871313821947,0,0,11
59,Ferroptosis WP4313,0.11510841513754018,1.7036498120528678,3.6830879112673616,"['PRNP', 'MAP1LC3B', 'TF', 'GCLC', 'TFRC', 'FTH1', 'PCBP1', 'ATG7', 'ATG5', 'FTL']",0.9999871313821947,0,0,10
60,Osteopontin Signaling WP1434,0.11513976802693429,2.724258923169994,5.8887812838658915,"['IKBKB', 'MAP2K1', 'CHUK', 'MAPK3']",0.9999871313821947,0,0,4
61,Glycerophospholipid Biosynthetic Pathway WP2533,0.12190503404741747,1.8168746718365039,3.823636269618764,"['PCYT2', 'GK', 'GPAM', 'PTPMT1', 'IPMK', 'CHPT1', 'CEPT1', 'LPIN1']",0.9999871313821947,0,0,8
62,Insulin Signaling WP481,0.12354743626946935,1.2793685756240822,2.6753261340445524,"['PRKAA1', 'STXBP4', 'PIK3R4', 'SLC2A1', 'CBLB', 'PIK3C2A', 'IKBKB', 'RPS6KA3', 'GYS1', 'RPS6KA6', 'RPS6KA5', 'GRB14', 'ENPP1', 'MAP3K9', 'MAP3K7', 'EIF4E', 'MAP3K4', 'MAP2K5', 'MAPK3', 'MAP4K4', 'MAP3K2', 'MAP3K3', 'PTPN1', 'MAP2K1', 'MAP3K1', 'PDPK1', 'SORBS1', 'MAPK14', 'MYO1C', 'RHOJ', 'RAPGEF1', 'PIK3C3', 'MAP3K13', 'PFKM', 'ARF6']",0.9999871313821947,0,0,35
63,Estrogen signaling pathway WP712,0.12419654941906517,1.9075339147286823,3.9789057119975797,"['IKBKB', 'MAP2K1', 'CHUK', 'GPER1', 'GNAS', 'MAPK14', 'PRKACA']",0.9999871313821947,0,0,7
64,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.12419654941906517,1.9075339147286823,3.9789057119975797,"['PPP2CA', 'MAP2K1', 'CNP', 'FGF9', 'MAPK14', 'ATG5', 'MAPK3']",0.9999871313821947,0,0,7
65,Methionine De Novo and Salvage Pathway WP3580,0.12494105537727734,2.0435888122048675,4.2504873660670155,"['MSRA', 'MTAP', 'AHCY', 'AMD1', 'MSRB2', 'MSRB3']",0.9999871313821947,0,0,6
66,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.12494105537727734,2.0435888122048675,4.2504873660670155,"['NQO2', 'GCLC', 'GSTP1', 'KEAP1', 'MAPK14', 'NFE2L2']",0.9999871313821947,0,0,6
67,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.12494105537727734,2.0435888122048675,4.2504873660670155,"['ATF1', 'MAP2K1', 'RPS6KA5', 'MAPKAPK2', 'GNAS', 'MAPK3']",0.9999871313821947,0,0,6
68,Metabolic reprogramming in colon cancer WP4290,0.1287240596751657,1.6063110833853191,3.293073033355118,"['ACLY', 'LDHA', 'PDHA1', 'PKM', 'PGAM1', 'GOT2', 'SLC2A1', 'ENO1', 'TKT', 'GAPDH', 'PSPH']",0.9999871313821947,0,0,11
69,Regulation of Microtubule Cytoskeleton WP2038,0.1287240596751657,1.6063110833853191,3.293073033355118,"['TIAM1', 'ROCK1', 'CFL2', 'TAOK1', 'DVL1', 'LIMK1', 'MAPKAPK2', 'ABL1', 'TPPP', 'PRKACA', 'CLASP1']",0.9999871313821947,0,0,11
70,HIF1A and PPARG regulation of glycolysis WP2456,0.14243369185204943,3.06422351233672,5.9717999594550015,"['LDHA', 'SLC2A1', 'GAPDH']",0.9999871313821947,0,0,3
71,Type III interferon signaling WP2113,0.14243369185204943,3.06422351233672,5.9717999594550015,"['IFNLR1', 'TYK2', 'JAK1']",0.9999871313821947,0,0,3
72,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.14488928688781613,1.7210966347165624,3.324789293984223,"['IKBKB', 'TBK1', 'CHUK', 'DDX58', 'TYK2', 'MAPK14', 'MAP3K7', 'JAK1']",0.9999871313821947,0,0,8
73,Nuclear Receptors Meta-Pathway WP2882,0.147943230261715,1.2172216415310337,2.326021283637517,"['GSTP1', 'ABHD2', 'SLC2A1', 'KEAP1', 'SLC2A6', 'SLC2A8', 'PTPA', 'AKAP13', 'DNAJB1', 'RGS2', 'SCP2', 'FTH1', 'ENC1', 'SLC39A6', 'EP300', 'SLC39A7', 'POLK', 'SLC39A1', 'SLC19A2', 'GSTM3', 'CBR1', 'CPT1A', 'TGFB2', 'HSP90AA1', 'JUND', 'NCOA6', 'GPX3', 'NCOA3', 'SLC2A13', 'SLC39A11', 'AIP', 'ARNT', 'SMARCA1', 'SLC2A9', 'SLC6A6', 'SLC5A8', 'GCLC', 'GPAM', 'NAV3', 'BHLHE40', 'SPRY1', 'PPARA', 'FTL', 'NFE2L2']",0.9999871313821947,0,0,44
74,16p11.2 distal deletion syndrome WP4950,0.1497658351636884,1.7881540697674418,3.395136488340499,"['RABEP2', 'PRMT1', 'NFATC2', 'ATP2A1', 'TUFM', 'VAV2', 'SDCCAG8']",0.9999871313821947,0,0,7
75,Signal transduction through IL1R WP4496,0.1497658351636884,1.7881540697674418,3.395136488340499,"['IKBKB', 'TGFB2', 'MAP3K1', 'CHUK', 'IRAK2', 'MAPK14', 'MAP3K7']",0.9999871313821947,0,0,7
76,MAPK Signaling Pathway WP382,0.15023922809735324,1.2121359035023078,2.2976356070917117,"['LRRK2', 'CACNA1B', 'CACNA1A', 'ARRB1', 'IKBKB', 'FGF5', 'RPS6KA3', 'CACNG8', 'RPS6KA5', 'PPP3CC', 'FGF9', 'FLNB', 'PRKACA', 'CACNG2', 'PAK2', 'MAP3K7', 'MAP3K4', 'MAP2K5', 'MAP4K4', 'MAPK3', 'MAP3K2', 'NTRK2', 'DAXX', 'MAP2K1', 'TGFB2', 'JUND', 'MAP3K1', 'CHUK', 'PLA2G4B', 'NFATC3', 'RRAS2', 'MAPK14', 'TGFBR1', 'MAPK8IP1', 'CDC25B', 'CACNB4', 'TAOK1', 'RASA1', 'MAPKAPK2', 'RASA2', 'NF1', 'TAB2', 'KRAS', 'MAP3K13', 'LAMTOR3']",0.9999871313821947,0,0,45
77,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.15373771952135842,1.886222023526782,3.531964411366954,"['PRKAA1', 'LDHA', 'PDHA1', 'SLC2A1', 'KEAP1', 'NFE2L2']",0.9999871313821947,0,0,6
78,Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,0.1558362204451657,2.04320987654321,3.798224371043356,"['HADHA', 'ACADVL', 'CPT1A', 'SCP2', 'SLC25A20']",0.9999871313821947,0,0,5
79,Interferon type I signaling pathways WP585,0.1595218605348849,1.4867127775755369,2.728971780128388,"['RPTOR', 'RPS6KA5', 'MAP3K1', 'PRMT1', 'MAPKAP1', 'RAPGEF1', 'FYN', 'TYK2', 'GAB2', 'MAPK14', 'EIF4E', 'JAK1']",0.9999871313821947,0,0,12
80,G13 Signaling Pathway WP524,0.16217897353092972,1.599509881422925,2.9095960933516807,"['ROCK1', 'CFL2', 'TNK2', 'LIMK1', 'ARHGDIG', 'PIP4K2A', 'IQGAP1', 'SH3RF1', 'MAP3K4']",0.9999871313821947,0,0,9
81,Vitamin D-sensitive calcium signaling in depression WP4698,0.16217897353092972,1.599509881422925,2.9095960933516807,"['GRIN2A', 'GRM5', 'GCLC', 'CHRM1', 'ITPR1', 'ATP2B3', 'ATP2B1', 'GRIN2D', 'NFE2L2']",0.9999871313821947,0,0,9
82,Irinotecan pathway WP229,0.17580301937944545,4.08487486398259,7.101110184941907,"['ABCC1', 'NPC1']",0.9999871313821947,0,0,2
83,miR-517 relationship with ARCN1 and USP1 WP3596,0.17580301937944545,4.08487486398259,7.101110184941907,"['USP1', 'ARCN1']",0.9999871313821947,0,0,2
84,Secretion of Hydrochloric Acid in Parietal Cells WP2597,0.17580301937944545,4.08487486398259,7.101110184941907,"['ATP4A', 'CHRM1']",0.9999871313821947,0,0,2
85,Aryl Hydrocarbon Receptor Pathway WP2873,0.177559440104694,1.6828189124487005,2.908668100661409,"['HSP90AA1', 'JUND', 'AIP', 'EP300', 'ARNT', 'POLK', 'NFE2L2']",0.9999871313821947,0,0,7
86,One-carbon metabolism WP241,0.177559440104694,1.6828189124487005,2.908668100661409,"['MTFMT', 'AHCYL2', 'MTRR', 'AHCY', 'MTHFD1L', 'DNMT3A', 'GLRX']",0.9999871313821947,0,0,7
87,T-cell receptor (TCR) signaling pathway WP69,0.17814220322730076,1.362984566776036,2.3513843826930625,"['MAP2K1', 'CD83', 'CHUK', 'PDPK1', 'ITPR1', 'NFATC2', 'CBLB', 'GAB2', 'MAPK14', 'MALT1', 'IKBKB', 'LCP2', 'FYN', 'MAP3K7', 'NCK1', 'MAPK3']",0.9999871313821947,0,0,16
88,DNA damage response WP707,0.17949993243112242,1.3960815673730507,2.397882403210202,"['RB1', 'H2AFX', 'RPA2', 'RAD52', 'PIDD1', 'CDK6', 'RRM2B', 'CDK5', 'CHEK1', 'TLK2', 'ABL1', 'TLK1', 'ATM', 'ATR']",0.9999871313821947,0,0,14
89,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.18636840730227477,1.5327272727272727,2.5750276157925214,"['NTRK2', 'GABRA1', 'GABRB1', 'SLC12A5', 'ROCK1', 'CREM', 'AP2B1', 'GABRD', 'GABRG3']",0.9999871313821947,0,0,9
90,p38 MAPK Signaling Pathway WP400,0.18636840730227477,1.5327272727272727,2.5750276157925214,"['TGFB2', 'DAXX', 'RPS6KA5', 'MAP3K1', 'MAPKAPK2', 'MAP3K9', 'MAPK14', 'MAP3K7', 'TGFBR1']",0.9999871313821947,0,0,9
91,Parkinson's disease pathway WP2371,0.18636840730227477,1.5327272727272727,2.5750276157925214,"['PRKN', 'UCHL1', 'PINK1', 'LRRK2', 'HTRA2', 'CASP2', 'UBE2L6', 'EPRS', 'MAPK14']",0.9999871313821947,0,0,9
92,Type 2 papillary renal cell carcinoma WP4241,0.18636840730227477,1.5327272727272727,2.5750276157925214,"['SETD2', 'TGFB2', 'EGLN3', 'EGLN2', 'CADM2', 'SLC2A1', 'TFEB', 'EP300', 'ARNT']",0.9999871313821947,0,0,9
93,VEGFA-VEGFR2 Signaling Pathway WP3888,0.19268774315573592,1.1274416246294658,1.8565404353181183,"['KCNC3', 'FAF1', 'CLTC', 'LDB2', 'EPRS', 'HERPUD1', 'RPS6KA5', 'BSG', 'CAPN2', 'SH3BGRL3', 'CHAC1', 'RPS11', 'IER5', 'NCK1', 'TMOD1', 'ACOT9', 'MAP2K1', 'HSP90AA1', 'PDPK1', 'IGFBP3', 'TRPC1', 'ARNT', 'ADAM10', 'FRS2', 'SND1', 'EPN1', 'VAV2', 'ARMCX1', 'EWSR1', 'MAPKAPK2', 'RHOJ', 'AKT1S1', 'RAPGEF1', 'NUMB', 'ADAM9', 'PRKD1', 'TKT', 'ATP6V0D1', 'ATF6', 'GAPDH', 'VCL', 'ARF6', 'HDAC4', 'PRKAA1', 'CNP', 'ROCK1', 'MAPKAP1', 'IQGAP1', 'HDAC9', 'HDAC7', 'PPP2CA', 'SDCBP', 'LDHA', 'FXR2', 'DNAJB4', 'MYO6', 'ABL1', 'DNAJB9', 'FLNB', 'FYN', 'EIF4E', 'PAK2', 'TXNDC5', 'MAPK3', 'PTPN1', 'RBM39', 'LIMK1', 'NFATC2', 'TRIP4', 'MICAL2', 'PDE4DIP', 'STAM', 'SOD2', 'MAPK14', 'MYO1C', 'SPIRE1', 'PTPN9', 'TPP1', 'EIF4G1']",0.9999871313821947,0,0,79
94,Iron metabolism in placenta WP2007,0.19591706009897641,2.4511611030478955,3.9955491587030254,"['TF', 'TFRC', 'FTH1']",0.9999871313821947,0,0,3
95,Leptin and adiponectin WP3934,0.19591706009897641,2.4511611030478955,3.9955491587030254,"['PRKAA1', 'CPT1A', 'ADIPOR1']",0.9999871313821947,0,0,3
96,NLR Proteins WP288,0.19591706009897641,2.4511611030478955,3.9955491587030254,"['IKBKB', 'CHUK', 'MAP3K7']",0.9999871313821947,0,0,3
97,Canonical and non-canonical TGF-B signaling WP3874,0.19678195954237485,2.042831215970962,3.320946885450282,"['SMAD2', 'MAPK14', 'TGFBR1', 'BMPR1A']",0.9999871313821947,0,0,4
98,Ganglio Sphingolipid Metabolism WP1423,0.19678195954237485,2.042831215970962,3.320946885450282,"['ST8SIA3', 'B3GALT1', 'ST8SIA5', 'ST6GALNAC6']",0.9999871313821947,0,0,4
99,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.19678195954237485,2.042831215970962,3.320946885450282,"['SMAD2', 'CDH6', 'RUNX2', 'MAPK3']",0.9999871313821947,0,0,4
100,TGF-beta Receptor Signaling WP560,0.20027807984538804,1.4597515979836824,2.347351336734497,"['SMAD2', 'ZEB2', 'ZFYVE9', 'EP300', 'ZNF423', 'SMAD5', 'TGFBR1', 'RUNX2', 'JAK1', 'MAPK3']",0.9999871313821947,0,0,10
101,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.2032705905237657,1.215002775469925,1.9357633555203806,"['PRKAA1', 'DOCK3', 'IKBKB', 'PPP2CA', 'RPS6KA3', 'RPS6KA5', 'SIRPA', 'FYN', 'EIF4E', 'MAP2K5', 'GRIA3', 'NCK1', 'MAPK3', 'NSF', 'MAP3K2', 'NTRK2', 'MAP2K1', 'MAP3K1', 'CHUK', 'PDPK1', 'KIDINS220', 'BAD', 'FRS2', 'EEF2', 'MAPK14', 'VAV2', 'TIAM1', 'DLG1', 'CDK5', 'CDK5R1']",0.9999871313821947,0,0,30
102,Modulators of TCR signaling and T cell activation WP5072,0.2121500529368385,1.4050218340611353,2.178432201090943,"['IKBKB', 'TMEM222', 'FIBP', 'CHUK', 'PDPK1', 'RASA2', 'ARIH2', 'CBLB', 'LCP2', 'RPRD1B', 'MALT1']",0.9999871313821947,0,0,11
103,miRNA regulation of DNA damage response WP1530,0.21853006335860778,1.3309103232092176,2.0240905883244227,"['RB1', 'H2AFX', 'RPA2', 'RAD52', 'PIDD1', 'CDK6', 'RRM2B', 'CDK5', 'CHEK1', 'TLK2', 'ABL1', 'TLK1', 'ATM', 'ATR']",0.9999871313821947,0,0,14
104,IL-1 signaling pathway WP195,0.22241443979642037,1.3624560126198277,2.0480613061232273,"['IKBKB', 'MAP3K2', 'MAP3K3', 'MAP2K1', 'MAP3K1', 'CHUK', 'IRAK2', 'MAPKAPK2', 'TAB2', 'MAPK14', 'MAP3K7', 'MAPK3']",0.9999871313821947,0,0,12
105,MAPK Cascade WP422,0.22480779155544844,1.4860050890585241,2.2178767148741505,"['MAP3K2', 'MAP3K3', 'MAP2K1', 'MAP3K1', 'KRAS', 'MAPK14', 'LAMTOR3', 'MAPK3']",0.9999871313821947,0,0,8
106,Ebstein-Barr virus LMP1 signaling WP262,0.2307037601073815,1.7023723069474703,2.4967346606692007,"['IKBKB', 'MAP3K3', 'HSP90AA1', 'CHUK', 'MAP3K7']",0.9999871313821947,0,0,5
107,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.2307037601073815,1.7023723069474703,2.4967346606692007,"['RAB5B', 'PDCD6IP', 'RRAS2', 'KRAS', 'MAPK3']",0.9999871313821947,0,0,5
108,Genes related to primary cilium development (based on CRISPR) WP4536,0.23405949822215344,1.2213345864661653,1.7735975743272963,"['DYNC2H1', 'TTC26', 'TRAF3IP1', 'IFT140', 'IFT172', 'CEP295', 'IFT80', 'CPLANE1', 'RPGRIP1L', 'MIB1', 'IFT52', 'BBS10', 'ARL13B', 'WDR60', 'CDK20', 'TRAPPC11', 'FGFR1OP', 'WDPCP', 'CEP192', 'IFT46', 'PIBF1', 'BBS5', 'CEP44']",0.9999871313821947,0,0,23
109,Phosphodiesterases in neuronal function WP4222,0.23592414711414392,1.3623241145075207,1.9675297037769488,"['GUCY1A1', 'GRIN2A', 'GUCY1B1', 'PDE1C', 'PDE1A', 'NOS1', 'PDE7B', 'PDE7A', 'PDE8A', 'ADCY5', 'GRIN2D']",0.9999871313821947,0,0,11
110,Lipid Metabolism Pathway WP3965,0.23880576846078977,1.5054123317013464,2.1559081384762466,"['ACLY', 'PRKAA1', 'PDHA1', 'PRKAR1B', 'PRKAR2A', 'ABHD5', 'PRKACA']",0.9999871313821947,0,0,7
111,Nuclear receptors WP170,0.23880576846078977,1.5054123317013464,2.1559081384762466,"['AR', 'THRB', 'NR2F1', 'RARA', 'NR2C2', 'PPARA', 'NR2F6']",0.9999871313821947,0,0,7
112,"GPCRs, Other WP117",0.23897424962123218,1.4145734265734267,2.024819660182661,"['CHRM3', 'GPR162', 'GPR176', 'GPR88', 'OR2M4', 'GPR83', 'ACKR1', 'CELSR2', 'GPR135']",0.9999871313821947,0,0,9
113,15q13.3 copy number variation syndrome WP4942,0.25320514318419607,2.042452830188679,2.80542186126388,"['OTUD7A', 'FYN', 'FAN1']",0.9999871313821947,0,0,3
114,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.25320514318419607,2.042452830188679,2.80542186126388,"['SMURF1', 'RUNX2', 'BMPR1A']",0.9999871313821947,0,0,3
115,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.25320514318419607,2.042452830188679,2.80542186126388,"['MAP2K1', 'MAFK', 'NFE2L2']",0.9999871313821947,0,0,3
116,Matrix Metalloproteinases WP129,0.25320514318419607,2.042452830188679,2.80542186126388,"['BSG', 'TIMP2', 'TCF20']",0.9999871313821947,0,0,3
117,Serotonin and anxiety-related events WP3944,0.25320514318419607,2.042452830188679,2.80542186126388,"['NLGN1', 'PLCD4', 'GRIN2D']",0.9999871313821947,0,0,3
118,Regulatory circuits of the STAT3 signaling pathway WP4538,0.25358584205767964,1.2958893645746363,1.7780287423755468,"['IL11RA', 'MAPKAP1', 'SETD7', 'LIFR', 'IFNLR1', 'TYK2', 'MAPK14', 'RPTOR', 'PTPRD', 'DEPTOR', 'AKT1S1', 'JAK1', 'MAPK3']",0.9999871313821947,0,0,13
119,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.2537842993429351,1.1966290631827707,1.6409022390124008,"['GABRA1', 'NTRK2', 'CPT1A', 'THRB', 'CREM', 'ATP1A3', 'TACR1', 'HDAC9', 'HSPD1', 'HADHB', 'AR', 'HADHA', 'TF', 'PRKAR1B', 'DEAF1', 'PRKAR2A', 'BHLHE40', 'SP3', 'EP300', 'TPPP', 'PRKACA', 'GAPDH', 'CC2D1A', 'YWHAG']",0.9999871313821947,0,0,24
120,Nanoparticle triggered autophagic cell death WP2509,0.25423499383110365,1.5321467490010898,2.0982692534194993,"['VMP1', 'BECN1', 'ATG4A', 'AMBRA1', 'ATG7', 'ATG5']",0.9999871313821947,0,0,6
121,Acetylcholine Synthesis WP528,0.2560581396745675,2.7230081005924314,3.709692134045052,"['PCYT1A', 'PDHA1']",0.9999871313821947,0,0,2
122,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.2560581396745675,2.7230081005924314,3.709692134045052,"['GSTP1', 'COX5A']",0.9999871313821947,0,0,2
123,Complement Activation WP545,0.2560581396745675,2.7230081005924314,3.709692134045052,"['C5', 'C1S']",0.9999871313821947,0,0,2
124,Molybdenum cofactor (Moco) biosynthesis WP4507,0.2560581396745675,2.7230081005924314,3.709692134045052,"['MARC2', 'GPHN']",0.9999871313821947,0,0,2
125,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.2560581396745675,2.7230081005924314,3.709692134045052,"['NKRF', 'FYN']",0.9999871313821947,0,0,2
126,TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer WP2868,0.2560581396745675,2.7230081005924314,3.709692134045052,"['JAK1', 'MAPK3']",0.9999871313821947,0,0,2
127,The alternative pathway of fetal androgen synthesis WP4524,0.2560581396745675,2.7230081005924314,3.709692134045052,"['POR', 'AKR1C2']",0.9999871313821947,0,0,2
128,Pathways Regulating Hippo Signaling WP4540,0.25833178189207234,1.2408565176617694,1.6795123801148064,"['SMAD2', 'NTRK2', 'PRKAA1', 'FLT3', 'GNAI3', 'CDH8', 'GNAI2', 'CDH6', 'LATS1', 'PRKAR1B', 'PRKAR2A', 'CDH10', 'GNAS', 'CDH12', 'PRKACA', 'PLCB1', 'PLCB2']",0.9999871313821947,0,0,17
129,Exercise-induced Circadian Regulation WP410,0.26064253281521144,1.3221380255158832,1.7777539504680633,"['GSTM3', 'BTG1', 'VAPA', 'TUBB3', 'GSTP1', 'SUMO3', 'TAB2', 'ERC2', 'ARNTL', 'HERPUD1', 'ETV6']",0.9999871313821947,0,0,11
130,Translation Factors WP107,0.2691434302855159,1.2905178855402066,1.6938187183634428,"['EIF5A', 'EEF1G', 'EIF2B3', 'EEF2K', 'EIF2S3', 'EIF2AK1', 'EIF3G', 'EEF2', 'GSPT2', 'EIF4E', 'EIF3A', 'EIF4G1']",0.9999871313821947,0,0,12
131,Heart Development WP1591,0.27138172164835683,1.571280934026032,2.0493099762606874,"['HEY1', 'BHLHE40', 'NFATC3', 'NFATC2', 'BMPR1A']",0.9999871313821947,0,0,5
132,miRNAs involvement in the immune response in sepsis WP4329,0.27138172164835683,1.571280934026032,2.0493099762606874,"['IKBKB', 'CHUK', 'TAB2', 'MAPK14', 'MAP3K7']",0.9999871313821947,0,0,5
133,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.27138172164835683,1.571280934026032,2.0493099762606874,"['MAP2K1', 'MAPKAPK2', 'ITPR1', 'KRAS', 'MAPK3']",0.9999871313821947,0,0,5
134,Folate Metabolism WP176,0.2852013564735132,1.3619289955167817,1.708621414855125,"['MTRR', 'AHCY', 'GPX3', 'RFK', 'NOS1', 'HBA1', 'SOD2', 'LDLR']",0.9999871313821947,0,0,8
135,IL-18 signaling pathway WP4754,0.28893075991279665,1.1230271333885666,1.3943147817763009,"['PRKAA1', 'PIGT', 'CD83', 'STOML1', 'MEPCE', 'ENO1', 'KLC1', 'PTMS', 'TMEM165', 'RPTOR', 'IKBKB', 'ABHD16A', 'GRM7', 'BSG', 'NFKBIZ', 'LONP2', 'TRPM7', 'LRRFIP1', 'RPS11', 'MAP3K7', 'MAPK3', 'CPT1A', 'USP5', 'CHUK', 'BAD', 'ECH1', 'TACR1', 'FOXN3', 'EEF2', 'RUNX2', 'LARS2', 'TF', 'UCK1', 'CLDN12', 'ZNF219', 'HDGF', 'KIFC3', 'APBA2', 'ARF6']",0.9999871313821947,0,0,39
136,Kennedy pathway from sphingolipids WP3933,0.29061832878310523,1.6339745916515427,2.0191750455396416,"['PCYT1A', 'PCYT2', 'CHPT1', 'CEPT1']",0.9999871313821947,0,0,4
137,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.29061832878310523,1.6339745916515427,2.0191750455396416,"['MAP3K1', 'ROCK1', 'FGF9', 'MAP3K4']",0.9999871313821947,0,0,4
138,SARS coronavirus and innate immunity WP4912,0.29061832878310523,1.6339745916515427,2.0191750455396416,"['TBK1', 'DDX58', 'TYK2', 'JAK1']",0.9999871313821947,0,0,4
139,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.29061832878310523,1.6339745916515427,2.0191750455396416,"['IKBKB', 'TBK1', 'CHUK', 'ITPR1']",0.9999871313821947,0,0,4
140,Type II diabetes mellitus WP1584,0.29061832878310523,1.6339745916515427,2.0191750455396416,"['IKBKB', 'GK', 'KCNJ11', 'CACNA1A']",0.9999871313821947,0,0,4
141,Amino Acid metabolism WP3925,0.29377811725454017,1.210893722742064,1.483260652992397,"['PDHX', 'OAT', 'PDHA1', 'HIBADH', 'MCCC1', 'GOT2', 'ASNS', 'EPRS', 'ADH5', 'ACLY', 'LARS2', 'LDHA', 'PKM', 'TDO2', 'AUH', 'ALDH18A1']",0.9999871313821947,0,0,16
142,Common Pathways Underlying Drug Addiction WP2636,0.29603727360829585,1.3132987012987014,1.5986389896130866,"['PPP1CC', 'GRIN2A', 'GRM5', 'MAP2K1', 'GNAS', 'PRKACA', 'ACTB', 'GRIA3', 'MAPK3']",0.9999871313821947,0,0,9
143,Wnt signaling pathway and pluripotency WP399,0.29833830416177215,1.1978545738071884,1.4488376737142985,"['CTBP2', 'LRRK2', 'PPP2R2A', 'AXIN2', 'PPP2R5C', 'PPP2R3A', 'LRP6', 'PPP2CA', 'PTPA', 'PPP2R1B', 'PPP2R1A', 'PPP2R2B', 'DVL1', 'EP300', 'PRKD1', 'MAP3K7', 'LDLR']",0.9999871313821947,0,0,17
144,Hippo-Merlin Signaling Dysregulation WP4541,0.30244943540403135,1.18649892316202,1.4188642618689358,"['NTRK2', 'FLT3', 'CDH8', 'CDH6', 'DCAF1', 'LATS1', 'CUL4A', 'PPP1CC', 'LIN28B', 'PRKAR1B', 'PRKAR2A', 'CDH10', 'CDH12', 'PAK6', 'KRAS', 'PRKACA', 'PAK2', 'VGLL4']",0.9999871313821947,0,0,18
145,Eukaryotic Transcription Initiation WP405,0.30493598470526695,1.2768279374317935,1.5164290546608645,"['POLR2A', 'POLR3B', 'TAF13', 'POLR2C', 'TAF9', 'ILK', 'TAF7', 'GTF2H1', 'TAF6', 'MNAT1']",0.9999871313821947,0,0,10
146,Neuroinflammation WP4919,0.31237601108657675,1.7505183495749534,2.036811517287285,"['CHUK', 'ASCC1', 'MAPK14']",0.9999871313821947,0,0,3
147,Cell cycle WP179,0.31266213252750263,1.1598029731703947,1.3484241897813602,"['RB1', 'SMAD2', 'TGFB2', 'CDC14B', 'CDC25B', 'ORC5', 'MAD2L2', 'CCNA1', 'CDK6', 'STAG2', 'DBF4', 'RAD21', 'CHEK1', 'ABL1', 'MCM3', 'EP300', 'ATM', 'SKP2', 'MAD1L1', 'YWHAG', 'ATR']",0.9999871313821947,0,0,21
148,Canonical and non-canonical Notch signaling WP3845,0.313397431026656,1.4589169000933706,1.6927566908859208,"['HEY1', 'CHUK', 'CNTN6', 'ADAM10', 'PSEN1']",0.9999871313821947,0,0,5
149,IL-7 signaling pathway WP205,0.313397431026656,1.4589169000933706,1.6927566908859208,"['MAP2K1', 'BAD', 'FYN', 'JAK1', 'MAPK3']",0.9999871313821947,0,0,5
150,Monoamine GPCRs WP58,0.313397431026656,1.4589169000933706,1.6927566908859208,"['CHRM3', 'CHRM1', 'HTR1E', 'CHRM5', 'ADRA2C']",0.9999871313821947,0,0,5
151,TLR4 Signaling and Tolerance WP3851,0.313397431026656,1.4589169000933706,1.6927566908859208,"['IKBKB', 'TBK1', 'CHUK', 'TAB2', 'MAP3K7']",0.9999871313821947,0,0,5
152,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.3168278957084044,1.307335514358415,1.5026469537984886,"['RPS6KA3', 'MAP2K1', 'MAP3K1', 'MAP3K9', 'MAPK14', 'EIF4E', 'MAP3K4', 'MAPK3']",0.9999871313821947,0,0,8
153,TGF-beta Signaling Pathway WP366,0.3205268147419315,1.140563751541176,1.297721278983281,"['NUP214', 'SMAD2', 'MAP2K1', 'JUND', 'SMURF2', 'ROCK1', 'ZFYVE9', 'SMURF1', 'LIMK2', 'MAPK14', 'PIAS2', 'RUNX2', 'TGFBR1', 'PJA1', 'EID2', 'ZEB2', 'ZFYVE16', 'PRKAR2A', 'EP300', 'BTRC', 'DCP1A', 'MAP3K7', 'PAK2', 'RNF111']",0.9999871313821947,0,0,24
154,PDGF Pathway WP2526,0.3257556394740564,1.2678996865203762,1.4220861157022742,"['TIAM1', 'MAP2K1', 'MAP3K1', 'CHUK', 'RASA1', 'ARFIP2', 'JAK1', 'MAPK3', 'VAV2']",0.9999871313821947,0,0,9
155,Ebola Virus Pathway on Host WP4217,0.32866164181255003,1.1511346281412462,1.2808980078347785,"['VPS18', 'DDX58', 'CLTC', 'VPS4A', 'CLTB', 'DAB2IP', 'IQGAP1', 'ACTB', 'VAV2', 'TIAM1', 'TBK1', 'NPC1', 'C1QBP', 'RASA2', 'VPS41', 'TYRO3', 'EP300', 'FLNB', 'TOP1', 'MAPK3']",0.9999871313821947,0,0,20
156,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.32895545793293185,1.3616660612664973,1.5139451578708158,"['NEFL', 'MFN2', 'KIF1B', 'RABAC1', 'RAB11B', 'DNM2']",0.9999871313821947,0,0,6
157,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.33305292909367656,1.2380259488298775,1.3611524025325032,"['SMAD2', 'TGFB2', 'MAP2K1', 'KRAS', 'MAP3K9', 'LBR', 'SYNE1', 'ADCY5', 'MAPK3', 'PLEC']",0.9999871313821947,0,0,10
158,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.3366467589054206,2.0420747188973523,2.2232498169384387,"['POR', 'H6PD']",0.9999871313821947,0,0,2
159,exRNA mechanism of action and biogenesis WP2805,0.3366467589054206,2.0420747188973523,2.2232498169384387,"['DROSHA', 'DICER1']",0.9999871313821947,0,0,2
160,LDLRAD4 and what we know about it WP4904,0.3366467589054206,2.0420747188973523,2.2232498169384387,"['SMAD2', 'TGFBR1']",0.9999871313821947,0,0,2
161,miRNA Biogenesis WP2338,0.3366467589054206,2.0420747188973523,2.2232498169384387,"['DROSHA', 'DICER1']",0.9999871313821947,0,0,2
162,Role of Altered Glycolysation of MUC1 in Tumour Microenvironment WP4480,0.3366467589054206,2.0420747188973523,2.2232498169384387,"['IKBKB', 'CHUK']",0.9999871313821947,0,0,2
163,Glycosaminoglycan degradation WP4815,0.3396299954524309,1.4852994555353902,1.6039726579657365,"['NAGLU', 'HEXB', 'IDS', 'ARSB']",0.9999871313821947,0,0,4
164,Kynurenine Pathway and links to Cellular Senescence WP5044,0.3396299954524309,1.4852994555353902,1.6039726579657365,"['TDO2', 'EIF2AK1', 'EIF2AK4', 'NOS1']",0.9999871313821947,0,0,4
165,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.3396299954524309,1.4852994555353902,1.6039726579657365,"['ITPR1', 'LPP', 'VCL', 'MAPK3']",0.9999871313821947,0,0,4
166,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.3396299954524309,1.4852994555353902,1.6039726579657365,"['ABCD2', 'ABCD3', 'RARA', 'PPARA']",0.9999871313821947,0,0,4
167,22q11.2 copy number variation syndrome WP4657,0.3430093890721124,1.1492156147391464,1.2296577873873367,"['RTN4R', 'PRKN', 'RTL10', 'CBX5', 'OAT', 'TANGO2', 'CHRD', 'KLHL22', 'RTN4', 'MALT1', 'ARNTL', 'POLR2A', 'THAP7', 'DGCR6L', 'DROSHA', 'TNPO1', 'DEPDC5', 'KPNB1']",0.9999871313821947,0,0,18
168,Proximal tubule transport WP4917,0.34907585544562647,1.256941531750692,1.3228882632980405,"['ATP6V0B', 'SLC5A8', 'SLC2A1', 'SLC16A10', 'ATP1B1', 'ATP6V0C', 'ATP6V1C1', 'SLC26A6']",0.9999871313821947,0,0,8
169,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.3561512079223904,1.3615347373517308,1.4056483225387038,"['IKBKB', 'CHUK', 'IRAK2', 'RASSF5', 'CBLB']",0.9999871313821947,0,0,5
170,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.3561512079223904,1.3615347373517308,1.4056483225387038,"['RB1', 'PRKAA1', 'GOT2', 'SLC2A1', 'SIRT2']",0.9999871313821947,0,0,5
171,PKC-gamma calcium signaling pathway in ataxia WP4760,0.3561512079223904,1.3615347373517308,1.4056483225387038,"['ITPR1', 'CACNA1A', 'PLCB1', 'PLCB2', 'GRIA3']",0.9999871313821947,0,0,5
172,Vitamin B12 metabolism WP1533,0.3561512079223904,1.3615347373517308,1.4056483225387038,"['MTRR', 'MMAB', 'HBA1', 'SOD2', 'LDLR']",0.9999871313821947,0,0,5
173,TNF-alpha signaling pathway WP231,0.36141053593528844,1.1386387822697326,1.1588390861230193,"['MAP3K3', 'HSP90AA1', 'MAP3K1', 'CHUK', 'BAD', 'KSR2', 'IKBKB', 'PPP2CA', 'TBK1', 'PSMD2', 'RFK', 'KRAS', 'TAB2', 'BTRC', 'MAP3K7', 'NSMAF', 'MAPK3']",0.9999871313821947,0,0,17
174,Trans-sulfuration and one-carbon metabolism WP2525,0.36736270091876455,1.2898847190624583,1.2916978236908299,"['AHCYL2', 'GCLC', 'AHCY', 'MTHFD1L', 'DNMT3A', 'PSPH']",0.9999871313821947,0,0,6
175,Acute viral myocarditis WP4298,0.3701960314167038,1.1671953819751417,1.1598684285245464,"['SGCD', 'ENDOG', 'RASA1', 'ABL1', 'ILK', 'CASP2', 'FYN', 'NOS1', 'ACTB', 'JAK1', 'MAPK3', 'EIF4G1']",0.9999871313821947,0,0,12
176,Homologous recombination WP186,0.37179284672733337,1.531567489114659,1.5153611211204883,"['RAD52', 'ATM', 'RAD54B']",0.9999871313821947,0,0,3
177,Hypertrophy Model WP516,0.37179284672733337,1.531567489114659,1.5153611211204883,"['JUND', 'ADAM10', 'EIF4E']",0.9999871313821947,0,0,3
178,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.37179284672733337,1.531567489114659,1.5153611211204883,"['IKBKB', 'MAP3K1', 'CHUK']",0.9999871313821947,0,0,3
179,NO metabolism in cystic fibrosis WP4947,0.37179284672733337,1.531567489114659,1.5153611211204883,"['PRMT1', 'PRMT3', 'NOS1']",0.9999871313821947,0,0,3
180,RAS and bradykinin pathways in COVID-19 WP4969,0.37179284672733337,1.531567489114659,1.5153611211204883,"['ROCK1', 'SERPING1', 'NOS1']",0.9999871313821947,0,0,3
181,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.37179284672733337,1.531567489114659,1.5153611211204883,"['RAD21', 'MAD1L1', 'MAD2L1']",0.9999871313821947,0,0,3
182,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.3755070490014349,1.243159125379171,1.2176470581226957,"['LDHA', 'PDHA1', 'PKM', 'IGFBP3', 'SLC2A1', 'ARNT', 'MCL1']",0.9999871313821947,0,0,7
183,Fas ligand pathway and stress induction of heat shock proteins WP314,0.3816985454001134,1.2102804367435411,1.1656502927964658,"['RB1', 'DAXX', 'MAP3K1', 'FAF1', 'MAPKAPK2', 'PAK2', 'MAP3K7', 'ACTB']",0.9999871313821947,0,0,8
184,IL-3 signaling pathway WP286,0.3816985454001134,1.2102804367435411,1.1656502927964658,"['MAP2K1', 'BAD', 'RAPGEF1', 'FYN', 'GAB2', 'PRKACA', 'JAK1', 'MAPK3']",0.9999871313821947,0,0,8
185,Netrin-UNC5B signaling pathway WP4747,0.3816985454001134,1.2102804367435411,1.1656502927964658,"['PTPA', 'MAP2K1', 'PPP2R1B', 'FYN', 'MAPK14', 'RLF', 'PLEKHH1', 'MAPK3']",0.9999871313821947,0,0,8
186,"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",0.3888454709188668,1.3614035087719298,1.285945352201979,"['PRKAA1', 'MAP2K1', 'EIF4E', 'MAPK3']",0.9999871313821947,0,0,4
187,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.3888454709188668,1.3614035087719298,1.285945352201979,"['TBK1', 'DDX58', 'TYK2', 'JAK1']",0.9999871313821947,0,0,4
188,Cardiac Progenitor Differentiation WP2406,0.3990828341240623,1.276325344952796,1.1724149498195926,"['LIN28B', 'SIRPA', 'ROR2', 'THY1', 'MAPK14']",0.9999871313821947,0,0,5
189,Glycerolipids and Glycerophospholipids WP4722,0.3990828341240623,1.276325344952796,1.1724149498195926,"['PCYT1A', 'PCYT2', 'GPAM', 'CHPT1', 'AGPAT4']",0.9999871313821947,0,0,5
190,Joubert Syndrome WP4656,0.4021060931110208,1.114067055393586,1.0149588836348706,"['CEP164', 'CPLANE1', 'RPGRIP1L', 'NIN', 'ARL13B', 'DVL1', 'MYO6', 'ANKS6', 'NPHP4', 'ATM', 'B9D2', 'ZNF423', 'BBS5', 'CEP290', 'PIBF1']",0.9999871313821947,0,0,15
191,Zinc homeostasis WP3529,0.40592976920485174,1.225281511078823,1.1046833212157978,"['SLC30A6', 'SLC39A6', 'SLC39A11', 'SLC39A7', 'SLC39A1', 'MT3']",0.9999871313821947,0,0,6
192,Integrated breast cancer pathway WP1984,0.41079344367095677,1.0709000838675746,0.9527420671263714,"['ATF1', 'RB1', 'USP15', 'USP38', 'GDI1', 'MYCBP2', 'JAKMIP1', 'BACH1', 'CHEK1', 'ABL1', 'EP300', 'JAK1', 'SMAD2', 'CHUK', 'BAD', 'NCOA3', 'PPP4R3A', 'TGFBR1', 'CDC25B', 'HIPK2', 'AR', 'NF1', 'ATM', 'KRAS', 'MAP3K13', 'BMPR1A', 'ATR']",0.9999871313821947,0,0,27
193,Bile acids synthesis and enterohepatic circulation  WP4389,0.41433195866279154,1.6335146898803046,1.4392698544653506,"['LDLR', 'MAPK3']",0.9999871313821947,0,0,2
194,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.41433195866279154,1.6335146898803046,1.4392698544653506,"['DHCR24', 'LBR']",0.9999871313821947,0,0,2
195,DDX1 as a regulatory component of the Drosha microprocessor WP2942,0.41433195866279154,1.6335146898803046,1.4392698544653506,"['DROSHA', 'ATM']",0.9999871313821947,0,0,2
196,Glial Cell Differentiation WP2276,0.41433195866279154,1.6335146898803046,1.4392698544653506,"['CNP', 'TPPP']",0.9999871313821947,0,0,2
197,Ketogenesis and Ketolysis WP4742,0.41433195866279154,1.6335146898803046,1.4392698544653506,"['SLC2A1', 'SLC25A20']",0.9999871313821947,0,0,2
198,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.41433195866279154,1.6335146898803046,1.4392698544653506,"['AHCY', 'ADK']",0.9999871313821947,0,0,2
199,NAD Biosynthesis II (from tryptophan) WP2485,0.41433195866279154,1.6335146898803046,1.4392698544653506,"['TDO2', 'NADSYN1']",0.9999871313821947,0,0,2
200,Supression of HMGB1 mediated inflammation by THBD WP4479,0.41433195866279154,1.6335146898803046,1.4392698544653506,"['IKBKB', 'CHUK']",0.9999871313821947,0,0,2
201,Valproic acid pathway WP3871,0.41433195866279154,1.6335146898803046,1.4392698544653506,"['HADHB', 'HADHA']",0.9999871313821947,0,0,2
202,Complement system WP2806,0.4144570861019745,1.1669522770940437,1.0278350433551822,"['PRNP', 'C5', 'C1S', 'C1QBP', 'GNAI3', 'SERPING1', 'PRKACA', 'GNAI2']",0.9999871313821947,0,0,8
203,Airway smooth muscle cell contraction WP4962,0.4301297878280265,1.361272375423319,1.1484623285923323,"['ROCK1', 'GDI1', 'PLCB1']",0.9999871313821947,0,0,3
204,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.4301297878280265,1.361272375423319,1.1484623285923323,"['TRPC1', 'ITPR1', 'PLCB1']",0.9999871313821947,0,0,3
205,Purinergic signaling WP4900,0.43750444092558216,1.2565684768951557,1.0387654806196436,"['GNAZ', 'GNAI3', 'GNAS', 'GNAI2']",0.9999871313821947,0,0,4
206,Triacylglyceride synthesis WP325,0.43750444092558216,1.2565684768951557,1.0387654806196436,"['GK', 'GPAM', 'MOGAT1', 'AGPAT4']",0.9999871313821947,0,0,4
207,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.43750444092558216,1.2565684768951557,1.0387654806196436,"['FLT3', 'RARA', 'AXIN2', 'LRP6']",0.9999871313821947,0,0,4
208,Sphingolipid Metabolism (integrated pathway) WP4726,0.4416851245487415,1.2011405869537357,0.9815216862045083,"['CERS5', 'CERS6', 'SGMS1', 'DEGS1', 'SGPP2']",0.9999871313821947,0,0,5
209,GABA receptor Signaling WP4159,0.44428782226241753,1.16683098956982,0.9466297702638491,"['GABRA1', 'GABRB1', 'AP2B1', 'GABRD', 'GABRG3', 'GPHN']",0.9999871313821947,0,0,6
210,Intraflagellar transport proteins binding to dynein WP4532,0.44428782226241753,1.16683098956982,0.9466297702638491,"['DYNC2H1', 'IFT140', 'WDR60', 'IFT80', 'DYNLRB1', 'IFT46']",0.9999871313821947,0,0,6
211,Energy Metabolism WP1541,0.447882594377946,1.1138181818181818,0.8946456590409059,"['PRKAA1', 'PPP3CC', 'MYBBP1A', 'PRMT1', 'EP300', 'NRF1', 'MAPK14', 'PPARA', 'CAMK2G']",0.9999871313821947,0,0,9
212,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.44837591540859534,1.1037920423151417,0.8853773171710702,"['IKBKB', 'CYLD', 'TBK1', 'TKFC', 'MAP3K1', 'CHUK', 'DDX58', 'MAPK14', 'MAP3K7', 'ATG5']",0.9999871313821947,0,0,10
213,Rett syndrome causing genes WP4312,0.44837591540859534,1.1037920423151417,0.8853773171710702,"['SRRM3', 'GRIN2A', 'TAF1B', 'FOXG1', 'SATB2', 'IMPDH2', 'HTT', 'HDAC8', 'SMARCA1', 'GABRD']",0.9999871313821947,0,0,10
214,Ciliopathies WP4803,0.47473088319202134,1.0290330870357376,0.7666370560039408,"['TRAF3IP1', 'IFT172', 'CEP164', 'PIK3R4', 'LRRC6', 'FLCN', 'IFT52', 'ARL13B', 'TBC1D32', 'POC1B', 'NPHP4', 'ZNF423', 'PIBF1', 'BBS5', 'CEP290', 'DYNC2H1', 'IQCB1', 'CFAP52', 'IFT140', 'DNAAF5', 'IFT80', 'CPLANE1', 'RPGRIP1L', 'BBS10', 'ARL2BP', 'WDR60', 'GPR161', 'ALMS1', 'ANKS6', 'WDPCP', 'B9D2', 'SDCCAG8']",0.9999871313821947,0,0,32
215,Genotoxicity pathway WP4286,0.477123604140382,1.0746491547165475,0.7952185521108519,"['RRM2B', 'EI24', 'SEL1L', 'PCDH8', 'ITPR1', 'CBLB', 'TM7SF3', 'FBXO22', 'SMAD5', 'PHLDA3']",0.9999871313821947,0,0,10
216,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.477123604140382,1.0746491547165475,0.7952185521108519,"['IKBKB', 'SP3', 'KRAS', 'TYK2', 'PLCB1', 'MAPK14', 'PLCB2', 'CAMK2G', 'JAK1', 'MAPK3']",0.9999871313821947,0,0,10
217,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.480762914064773,1.0994241949910555,0.8051974271322988,"['RPTOR', 'SMAD2', 'DEPTOR', 'MAPKAP1', 'AKT1S1', 'ILK', 'EIF4E']",0.9999871313821947,0,0,7
218,Gene regulatory network modelling somitogenesis  WP2854,0.48175778521247614,2.0416968817984045,1.4910794317621565,['EPHA4'],0.9999871313821947,0,0,1
219,Hypothetical Craniofacial Development Pathway WP3655,0.48175778521247614,2.0416968817984045,1.4910794317621565,['ARHGAP29'],0.9999871313821947,0,0,1
220,Macrophage markers WP4146,0.48175778521247614,2.0416968817984045,1.4910794317621565,['CD83'],0.9999871313821947,0,0,1
221,Hematopoietic Stem Cell Differentiation WP2849,0.4835125135673746,1.1343096909545711,0.8242779919881044,"['THRB', 'HMGN5', 'MXI1', 'NFATC2', 'ACVR1B']",0.9999871313821947,0,0,5
222,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.4835125135673746,1.1343096909545711,0.8242779919881044,"['VMP1', 'LATS1', 'RASSF5', 'STK38L', 'MAPK14']",0.9999871313821947,0,0,5
223,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.4849680534643741,1.166709878143635,0.8443155735335331,"['H2AFX', 'H2AFV', 'MAPK3', 'EZH2']",0.9999871313821947,0,0,4
224,Monoamine Transport WP727,0.4849680534643741,1.166709878143635,0.8443155735335331,"['UNC13B', 'TDO2', 'NOS1', 'MAPK14']",0.9999871313821947,0,0,4
225,NAD+ biosynthetic pathways WP3645,0.4849680534643741,1.166709878143635,0.8443155735335331,"['TDO2', 'TNKS2', 'NADSYN1', 'SIRT2']",0.9999871313821947,0,0,4
226,Vitamin D in inflammatory diseases WP4482,0.4849680534643741,1.166709878143635,0.8443155735335331,"['IKBKB', 'MAP3K1', 'CHUK', 'MAPK14']",0.9999871313821947,0,0,4
227,Biomarkers for pyrimidine metabolism disorders WP4584,0.4863640825447086,1.2250362844702467,0.8830034520399384,"['RRM2B', 'DPYD', 'CKB']",0.9999871313821947,0,0,3
228,BMP Signaling Pathway in Eyelid Development WP3927,0.4863640825447086,1.2250362844702467,0.8830034520399384,"['MAP3K1', 'SMAD5', 'MAPK3']",0.9999871313821947,0,0,3
229,IL-9 signaling pathway WP22,0.4863640825447086,1.2250362844702467,0.8830034520399384,"['MAP2K1', 'MAPK3', 'JAK1']",0.9999871313821947,0,0,3
230,Nicotine Activity on Dopaminergic Neurons WP1602,0.4863640825447086,1.2250362844702467,0.8830034520399384,"['CDK5', 'PRKACA', 'KCNK3']",0.9999871313821947,0,0,3
231,Phytochemical activity on NRF2 transcriptional activation WP3,0.4863640825447086,1.2250362844702467,0.8830034520399384,"['GCLC', 'KEAP1', 'NFE2L2']",0.9999871313821947,0,0,3
232,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.4863640825447086,1.2250362844702467,0.8830034520399384,"['PFKFB4', 'LDHA', 'PDHA1']",0.9999871313821947,0,0,3
233,PPAR-alpha pathway WP2878,0.4863640825447086,1.2250362844702467,0.8830034520399384,"['CPT1A', 'SCP2', 'PPARA']",0.9999871313821947,0,0,3
234,Transcription co-factors SKI and SKIL protein partners WP4533,0.4863640825447086,1.2250362844702467,0.8830034520399384,"['LATS1', 'SATB2', 'NF1']",0.9999871313821947,0,0,3
235,Tryptophan catabolism leading to NAD+ production WP4210,0.4863640825447086,1.2250362844702467,0.8830034520399384,"['TDO2', 'NMNAT3', 'NADSYN1']",0.9999871313821947,0,0,3
236,ATR Signaling WP3875,0.48713688887982737,1.361141337202273,0.9789466100398454,"['CHEK1', 'ATR']",0.9999871313821947,0,0,2
237,Canonical NF-KB pathway WP4562,0.48713688887982737,1.361141337202273,0.9789466100398454,"['IKBKB', 'CHUK']",0.9999871313821947,0,0,2
238,"Degradation pathway of sphingolipids, including diseases WP4153",0.48713688887982737,1.361141337202273,0.9789466100398454,"['HEXB', 'NEU1']",0.9999871313821947,0,0,2
239,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.48713688887982737,1.361141337202273,0.9789466100398454,"['ZYG11B', 'UBA3']",0.9999871313821947,0,0,2
240,Vitamin B12 Disorders WP4271,0.48713688887982737,1.361141337202273,0.9789466100398454,"['MTRR', 'MMAB']",0.9999871313821947,0,0,2
241,Male infertility WP4673,0.4903909081908571,1.0352652213903633,0.7376807534513202,"['PACRG', 'MTRR', 'CCNT2', 'UBR2', 'SOD2', 'CLU', 'PUM2', 'ARNTL', 'AR', 'CCNA1', 'ABLIM1', 'EP300', 'SIRPA', 'ATM', 'NOS1', 'RAG1', 'SOX5', 'NFE2L2']",0.9999871313821947,0,0,18
242,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.4968952115980143,1.0394171220400727,0.7269435107254323,"['HDAC4', 'MAP2K1', 'CHUK', 'ROCK1', 'PDPK1', 'MAPK14', 'HDAC9', 'HDAC7', 'LRP6', 'IKBKB', 'DVL1', 'PLCB2', 'MAP2K5', 'MAPK3']",0.9999871313821947,0,0,14
243,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.49879906966943305,1.0408651443097268,0.723975760322709,"['APC2', 'SMAD2', 'MAP2K1', 'TGFB2', 'BAD', 'AXIN2', 'TGFBR1', 'TBK1', 'MSH3', 'KRAS', 'POLK', 'EXOC2', 'MAPK3']",0.9999871313821947,0,0,13
244,DNA IR-double strand breaks and cellular response via ATM WP3959,0.5055454825648743,1.0470007741742917,0.7141773088973974,"['LATS1', 'RAD52', 'UPF1', 'CDK5', 'CHEK1', 'H2AFX', 'ABL1', 'ATM', 'TERF2', 'ATR']",0.9999871313821947,0,0,10
245,G1 to S cell cycle control WP45,0.5055454825648743,1.0470007741742917,0.7141773088973974,"['RB1', 'ORC5', 'CCNA1', 'PRIM2', 'CDK6', 'CCNG2', 'MCM3', 'RPA2', 'ATM', 'MNAT1']",0.9999871313821947,0,0,10
246,Glucocorticoid Receptor Pathway WP2880,0.508276546713085,1.0499844155844156,0.7105555296093959,"['AKAP13', 'RGS2', 'HSP90AA1', 'NAV3', 'ABHD2', 'ENC1', 'BHLHE40', 'SPRY1', 'SLC19A2']",0.9999871313821947,0,0,9
247,IL-4 signaling pathway WP395,0.508276546713085,1.0499844155844156,0.7105555296093959,"['IKBKB', 'CHUK', 'BAD', 'EP300', 'TYK2', 'GAB2', 'MAPK14', 'JAK1', 'MAPK3']",0.9999871313821947,0,0,9
248,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.508276546713085,1.0499844155844156,0.7105555296093959,"['RPTOR', 'MAP2K1', 'RPS6KA5', 'PRKACA', 'MAPK14', 'EIF4E', 'MAP2K5', 'MAPK3', 'EIF4G1']",0.9999871313821947,0,0,9
249,Endochondral Ossification with Skeletal Dysplasias WP4808,0.5113587744444785,1.0537399889776151,0.7067263742724482,"['HDAC4', 'TGFB2', 'CHST11', 'ENPP1', 'PRKACA', 'RUNX2', 'SOX5', 'BMPR1A']",0.9999871313821947,0,0,8
250,Endochondral Ossification WP474,0.5113587744444785,1.0537399889776151,0.7067263742724482,"['HDAC4', 'TGFB2', 'CHST11', 'ENPP1', 'PRKACA', 'RUNX2', 'SOX5', 'BMPR1A']",0.9999871313821947,0,0,8
251,One-carbon metabolism and related pathways WP3940,0.5113587744444785,1.0537399889776151,0.7067263742724482,"['GCLC', 'PCYT2', 'PCYT1A', 'GPX3', 'DNMT3A', 'CHPT1', 'CEPT1', 'SOD2']",0.9999871313821947,0,0,8
252,DNA damage response (only ATM dependent) WP710,0.5134095665718345,1.0207877461706782,0.6805401802007318,"['MAP3K1', 'BAD', 'PIK3R4', 'PPP2R5C', 'PIK3C2A', 'SOD2', 'PIK3C2B', 'SCP2', 'CCNG2', 'DVL1', 'ABL1', 'ATM', 'PIK3C3', 'KRAS', 'MAP3K7', 'LDLR', 'MAP3K4']",0.9999871313821947,0,0,17
253,ATM Signaling Pathway WP2516,0.514903987363553,1.0586105727820845,0.7026790508704198,"['PIDD1', 'CHEK1', 'H2AFX', 'ABL1', 'CASP2', 'TLK1', 'ATM']",0.9999871313821947,0,0,7
254,Pancreatic adenocarcinoma pathway WP4263,0.5156368132773984,1.020780167699599,0.6761164099014672,"['RB1', 'SMAD2', 'MAP2K1', 'TGFB2', 'CHUK', 'BAD', 'TGFBR1', 'IKBKB', 'TIAM1', 'CDK6', 'PAK6', 'KRAS', 'POLK', 'PAK2', 'JAK1', 'MAPK3']",0.9999871313821947,0,0,16
255,Spinal Cord Injury WP2431,0.51802256342487,1.0207725947521866,0.6713993722667064,"['RB1', 'RTN4R', 'EPHA4', 'SEMA6A', 'OMG', 'XYLT1', 'MIF', 'TACR1', 'RTN4', 'LTB4R', 'C5', 'CHST11', 'PLXNA2', 'NOS1', 'MAPK3']",0.9999871313821947,0,0,15
256,Cell migration and invasion through p75NTR WP4561,0.52418540215059,1.0745136261132133,0.6940389203909753,"['NTRK2', 'TIAM1', 'EFNA3', 'ADAMTS13', 'KIDINS220']",0.9999871313821947,0,0,5
257,Neovascularisation processes WP4331,0.52418540215059,1.0745136261132133,0.6940389203909753,"['SMAD2', 'TGFB2', 'SMAD5', 'TGFBR1', 'MAPK3']",0.9999871313821947,0,0,5
258,Oxidative Stress WP408,0.52418540215059,1.0745136261132133,0.6940389203909753,"['GCLC', 'GPX3', 'MAPK14', 'SOD2', 'NFE2L2']",0.9999871313821947,0,0,5
259,Photodynamic therapy-induced unfolded protein response WP3613,0.52418540215059,1.0745136261132133,0.6940389203909753,"['UBE2E1', 'DNAJB9', 'ASNS', 'ATF6', 'NFE2L2']",0.9999871313821947,0,0,5
260,Sphingolipid pathway WP1422,0.52418540215059,1.0745136261132133,0.6940389203909753,"['PPP2CA', 'CERS5', 'CERS6', 'SGMS1', 'SGPP2']",0.9999871313821947,0,0,5
261,Head and Neck Squamous Cell Carcinoma WP4674,0.5264224223339794,1.0207499089916272,0.6549655104266673,"['RB1', 'RPTOR', 'PRKAA1', 'CDK6', 'PDPK1', 'MAPKAP1', 'NUMB', 'KEAP1', 'KRAS', 'CSMD3', 'EIF4E', 'NFE2L2']",0.9999871313821947,0,0,12
262,Melanoma WP4685,0.5264224223339794,1.0207499089916272,0.6549655104266673,"['RB1', 'GRM3', 'MAP2K1', 'GRIN2A', 'CDK6', 'BAD', 'NF1', 'KRAS', 'POLK', 'LAMTOR3', 'VCL', 'MAPK3']",0.9999871313821947,0,0,12
263,Ras signaling WP4223,0.5286753868176532,1.00278157862617,0.6391535954316758,"['RAB5B', 'FLT3', 'RASAL2', 'IKBKB', 'GRIN2A', 'RASSF5', 'ABL1', 'PAK6', 'PRKACA', 'PAK2', 'MAPK3', 'NTRK2', 'MAP2K1', 'CHUK', 'BAD', 'PLA2G4B', 'RRAS2', 'KSR2', 'GAB2', 'GNG13', 'TIAM1', 'RASA1', 'RASA2', 'NF1', 'KRAS', 'RIN1', 'EXOC2', 'ARF6']",0.9999871313821947,0,0,28
264,Integrin-mediated Cell Adhesion WP185,0.5375694687823049,1.0049861185114557,0.6237921532986912,"['GIT2', 'MAP2K1', 'ROCK1', 'PDPK1', 'ILK', 'SORBS1', 'VAV2', 'SELENOP', 'CAPN2', 'RAPGEF1', 'PAK6', 'FYN', 'ARHGEF7', 'PAK2', 'VCL', 'MAP2K5']",0.9999871313821947,0,0,16
265,RANKL/RANK signaling pathway WP2018,0.5377279266203027,1.0207272727272727,0.6332618123858578,"['IKBKB', 'MAP2K1', 'CHUK', 'TAB2', 'GAB2', 'MAPK14', 'MAP3K7', 'PAPSS2', 'MAPK3']",0.9999871313821947,0,0,9
266,Myometrial relaxation and contraction pathways WP289,0.5390950839680579,0.9989346149060595,0.6172050531607608,"['ATF1', 'RGS17', 'GUCY1A1', 'IGFBP3', 'ITPR1', 'ATP2A2', 'ARRB1', 'ACTB', 'GNG13', 'ADCY5', 'RGS2', 'PRKAR1B', 'CALD1', 'GRK4', 'PRKAR2A', 'GNAS', 'PRKD1', 'IGFBP6', 'NOS1', 'PRKACA', 'CAMK2G', 'RGS6', 'YWHAG']",0.9999871313821947,0,0,23
267,Differentiation of white and brown adipocyte WP2895,0.5397492572564805,1.1135703918722786,0.6866838343397239,"['CEBPG', 'ZNF423', 'SMAD5']",0.9999871313821947,0,0,3
268,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.5397492572564805,1.1135703918722786,0.6866838343397239,"['PPARA', 'PTGR2', 'LTB4R']",0.9999871313821947,0,0,3
269,Imatinib and Chronic Myeloid Leukemia WP3640,0.5397492572564805,1.1135703918722786,0.6866838343397239,"['ABL1', 'GAB2', 'SKP2']",0.9999871313821947,0,0,3
270,MAPK pathway in congenital thyroid cancer WP4928,0.5397492572564805,1.1135703918722786,0.6866838343397239,"['MAP2K1', 'KRAS', 'MAPK3']",0.9999871313821947,0,0,3
271,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.5397492572564805,1.1135703918722786,0.6866838343397239,"['IKBKB', 'EGLN2', 'CHUK']",0.9999871313821947,0,0,3
272,Prader-Willi and Angelman Syndrome WP3998,0.5425583741307417,1.0207197382769901,0.6241288800943223,"['RB1', 'HERC2', 'CDK6', 'NIPA1', 'SNURF', 'GNRH1', 'GABRG3', 'GABRD']",0.9999871313821947,0,0,8
273,Hepatitis C and Hepatocellular Carcinoma WP3646,0.5482053303390381,1.0207122093023255,0.6135555920870851,"['UCHL1', 'CTTN', 'MAPK14', 'TGFBR1', 'JAK1', 'VAV2', 'MAPK3']",0.9999871313821947,0,0,7
274,IL-6 signaling pathway WP364,0.5482053303390381,1.0207122093023255,0.6135555920870851,"['MAP2K1', 'BAD', 'TYK2', 'MAP3K7', 'JAK1', 'MAPK3', 'NR2F6']",0.9999871313821947,0,0,7
275,15q11.2 copy number variation syndrome WP4940,0.553974488266413,1.1665889424322504,0.6890301771341958,"['NIPA1', 'TUBGCP4']",0.9999871313821947,0,0,2
276,Autosomal recessive Osteopetrosis pathways WP4788,0.553974488266413,1.1665889424322504,0.6890301771341958,"['IKBKB', 'PLEKHM1']",0.9999871313821947,0,0,2
277,Biotin Metabolism (including IEMs) WP5031,0.553974488266413,1.1665889424322504,0.6890301771341958,"['HLCS', 'MCCC1']",0.9999871313821947,0,0,2
278,Estrogen Receptor Pathway WP2881,0.553974488266413,1.1665889424322504,0.6890301771341958,"['GPAM', 'PPARA']",0.9999871313821947,0,0,2
279,Glutathione metabolism WP100,0.553974488266413,1.1665889424322504,0.6890301771341958,"['GCLC', 'GPX3']",0.9999871313821947,0,0,2
280,Fatty acid beta-oxidation WP143,0.5549790800799947,1.020704685797312,0.6010162932011858,"['HADHB', 'HADHA', 'ACADVL', 'CPT1A', 'GK', 'SLC25A20']",0.9999871313821947,0,0,6
281,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.5549790800799947,1.020704685797312,0.6010162932011858,"['MAP2K1', 'ARRB1', 'KRAS', 'PLCB1', 'PLCB2', 'MAPK3']",0.9999871313821947,0,0,6
282,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.5549790800799947,1.020704685797312,0.6010162932011858,"['MAP2K1', 'FYN', 'GAB2', 'MAPK14', 'JAK1', 'MAPK3']",0.9999871313821947,0,0,6
283,Ethanol effects on histone modifications WP3996,0.5633910544199506,1.0206971677559913,0.5856569493674846,"['HDAC4', 'AHCY', 'HDAC8', 'HDAC9', 'HDAC7']",0.9999871313821947,0,0,5
284,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.5665001739941852,0.9930515970515971,0.5643292675992824,"['RPTOR', 'NTRK2', 'PRKAA1', 'GRIN2A', 'DLG4', 'NF1', 'KRAS', 'MAPK3', 'GRIN2D']",0.9999871313821947,0,0,9
285,Leptin signaling pathway WP2034,0.5713657159968899,0.9827762941382752,0.5500852386037297,"['PTPN1', 'MAP2K1', 'PRKAA1', 'CHUK', 'ROCK1', 'BAD', 'MAPK14', 'IKBKB', 'CFL2', 'FYN', 'EIF4E', 'JAK1', 'MAPK3']",0.9999871313821947,0,0,13
286,Cytosolic DNA-sensing pathway WP4655,0.5729358572330181,0.9897007148915545,0.5512449991579511,"['IKBKB', 'CYLD', 'TBK1', 'CHUK', 'POLR3B', 'DDX58', 'POLR3G', 'ATG5']",0.9999871313821947,0,0,8
287,Complement and Coagulation Cascades WP558,0.5743624139576903,1.0206896551724138,0.5659670028105586,"['C1S', 'CLTC', 'SERPING1', 'CLU']",0.9999871313821947,0,0,4
288,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.5743624139576903,1.0206896551724138,0.5659670028105586,"['YY1', 'PTPN1', 'CHUK', 'EIF4E']",0.9999871313821947,0,0,4
289,NRF2-ARE regulation WP4357,0.5743624139576903,1.0206896551724138,0.5659670028105586,"['GCLC', 'KEAP1', 'FYN', 'NFE2L2']",0.9999871313821947,0,0,4
290,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.5804893703065156,0.9854275260625501,0.535958056939654,"['TBK1', 'AP1G1', 'DDX58', 'BSG', 'EP300', 'NUP98', 'JAK1']",0.9999871313821947,0,0,7
291,Cells and molecules involved in local acute inflammatory response  WP4493,0.5837426276043014,1.3610103940053178,0.7326252253941582,['C5'],0.9999871313821947,0,0,1
292,Composition of Lipid Particles WP3601,0.5837426276043014,1.3610103940053178,0.7326252253941582,['LDLR'],0.9999871313821947,0,0,1
293,FTO Obesity Variant Mechanism WP3407,0.5837426276043014,1.3610103940053178,0.7326252253941582,['FTO'],0.9999871313821947,0,0,1
294,"Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases WP4518",0.5837426276043014,1.3610103940053178,0.7326252253941582,['GCLC'],0.9999871313821947,0,0,1
295,Nucleotide GPCRs WP80,0.5837426276043014,1.3610103940053178,0.7326252253941582,['LTB4R'],0.9999871313821947,0,0,1
296,Platelet-mediated interactions with vascular and circulating cells WP4462,0.5837426276043014,1.3610103940053178,0.7326252253941582,['TGFB2'],0.9999871313821947,0,0,1
297,Role of Osx and miRNAs in tooth development WP3971,0.5837426276043014,1.3610103940053178,0.7326252253941582,['RUNX2'],0.9999871313821947,0,0,1
298,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.5837426276043014,1.3610103940053178,0.7326252253941582,['EPHA4'],0.9999871313821947,0,0,1
299,Vitamin B6-dependent and responsive disorders WP4228,0.5837426276043014,1.3610103940053178,0.7326252253941582,['PNPO'],0.9999871313821947,0,0,1
300,B Cell Receptor Signaling Pathway WP23,0.5894867620765621,0.9686023895526535,0.5119092836466753,"['MAP2K1', 'CHUK', 'PDPK1', 'NFATC3', 'NFATC2', 'GAB2', 'MAPK14', 'MALT1', 'VAV2', 'IKBKB', 'RAPGEF1', 'FYN', 'MAP3K7', 'NCK1']",0.9999871313821947,0,0,14
301,BDNF-TrkB Signaling WP3676,0.5895780584828996,0.9797893207410098,0.5176698779833048,"['NTRK2', 'MAP2K1', 'EEF2K', 'DLG4', 'KRAS', 'GAB2']",0.9999871313821947,0,0,6
302,Oxidative Damage WP3941,0.5895780584828996,0.9797893207410098,0.5176698779833048,"['C5', 'MAP3K1', 'C1S', 'BAD', 'TNK2', 'MAP3K9']",0.9999871313821947,0,0,6
303,ERK Pathway in Huntington's Disease WP3853,0.5897790383318116,1.0206821480406385,0.5389276491630731,"['NTRK2', 'RPS6KA5', 'HTT']",0.9999871313821947,0,0,3
304,Overview of interferons-mediated signaling pathway WP4558,0.5897790383318116,1.0206821480406385,0.5389276491630731,"['IFNLR1', 'TYK2', 'JAK1']",0.9999871313821947,0,0,3
305,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.5897790383318116,1.0206821480406385,0.5389276491630731,"['DDR1', 'NRF1', 'NFE2L2']",0.9999871313821947,0,0,3
306,Prolactin Signaling Pathway WP2037,0.6002825859439819,0.9604488318807684,0.49016963123057106,"['PTPN1', 'MAP2K1', 'SIRPA', 'FYN', 'GAB2', 'MAPK14', 'CTSD', 'PPIA', 'YWHAG', 'JAK1', 'VAV2', 'MAPK3']",0.9999871313821947,0,0,12
307,Development of ureteric collection system WP5053,0.6008818116299813,0.9720060863851714,0.495098120324428,"['TGFB2', 'RARA', 'ILK', 'SPRY1', 'ROBO1']",0.9999871313821947,0,0,5
308,Endothelin Pathways WP2197,0.6008818116299813,0.9720060863851714,0.495098120324428,"['MAP2K1', 'GNAS', 'ATP2A2', 'PLCB1', 'GNG13']",0.9999871313821947,0,0,5
309,Androgen receptor signaling pathway WP138,0.6061864904828628,0.9566326530612245,0.47885931140084975,"['RB1', 'DAXX', 'ROCK1', 'NCOA3', 'LIMK2', 'RNF6', 'EFCAB6', 'NR2C2', 'PIAS2', 'RUNX2', 'AR', 'ZNF318', 'EP300', 'PAK6', 'STUB1']",0.9999871313821947,0,0,15
310,Regulation of toll-like receptor signaling pathway WP1449,0.6061864904828628,0.9566326530612245,0.47885931140084975,"['USP7', 'MAP2K1', 'CHUK', 'MAPK14', 'RNF41', 'IKBKB', 'CYLD', 'TBK1', 'RNF216', 'IRAK2', 'TAB2', 'TMED7', 'ZMYND11', 'MAP3K7', 'MAPK3']",0.9999871313821947,0,0,15
311,Alanine and aspartate metabolism WP106,0.6143740606323134,1.0206746463547334,0.49722299826436717,"['GOT2', 'GPT']",0.9999871313821947,0,0,2
312,Dopamine metabolism WP2436,0.6143740606323134,1.0206746463547334,0.49722299826436717,"['PPP2CA', 'PRKACA']",0.9999871313821947,0,0,2
313,miRNA regulation of p53 pathway in prostate cancer WP3982,0.6156046381389944,0.9605636810077933,0.46601779903277907,"['SESN3', 'ZMAT3', 'EI24', 'ATM']",0.9999871313821947,0,0,4
314,Sphingolipid Metabolism (general overview) WP4725,0.6156046381389944,0.9605636810077933,0.46601779903277907,"['CERS6', 'SGMS1', 'DEGS1', 'SGPP2']",0.9999871313821947,0,0,4
315,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.6156046381389944,0.9605636810077933,0.46601779903277907,"['ITPR1', 'P3H2', 'P3H1', 'LRP6']",0.9999871313821947,0,0,4
316,Hedgehog Signaling Pathway WP4249,0.6227140110859397,0.9420212914582693,0.4462052627226519,"['SMURF2', 'SMURF1', 'GPR161', 'SPOPL', 'ARRB1', 'PRKACA']",0.9999871313821947,0,0,6
317,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.6227140110859397,0.9420212914582693,0.4462052627226519,"['IKBKB', 'CHUK', 'TNFSF12', 'MAPK14', 'MAP3K7', 'MAPK3']",0.9999871313821947,0,0,6
318,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.6361482857996456,0.9420844032600201,0.4261269984659875,"['PLA2G4B', 'PRXL2B', 'PTGR2']",0.9999871313821947,0,0,3
319,Interactome of polycomb repressive complex 2 (PRC2)  WP2916,0.6361482857996456,0.9420844032600201,0.4261269984659875,"['MORC3', 'MTF2', 'EZH2']",0.9999871313821947,0,0,3
320,Microglia Pathogen Phagocytosis Pathway WP3937,0.6361482857996456,0.9420844032600201,0.4261269984659875,"['PIK3C3', 'PIK3C2A', 'VAV2']",0.9999871313821947,0,0,3
321,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.6361482857996456,0.9420844032600201,0.4261269984659875,"['CNP', 'OMG', 'SOX5']",0.9999871313821947,0,0,3
322,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.6361482857996456,0.9420844032600201,0.4261269984659875,"['PRKAA1', 'PPARA', 'LDLR']",0.9999871313821947,0,0,3
323,Urea cycle and metabolism of amino groups WP497,0.6361482857996456,0.9420844032600201,0.4261269984659875,"['OAT', 'CKB', 'ALDH18A1']",0.9999871313821947,0,0,3
324,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.636471327903723,0.9277414669571532,0.41916835374430117,"['IKBKB', 'HSP90AA1', 'CHUK', 'NOD1', 'AAMP']",0.9999871313821947,0,0,5
325,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.636471327903723,0.9277414669571532,0.41916835374430117,"['RPTOR', 'BAD', 'TFEB', 'KRAS', 'ATG13']",0.9999871313821947,0,0,5
326,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.636471327903723,0.9277414669571532,0.41916835374430117,"['ATF1', 'CAMK1D', 'ITPR1', 'CAMK2G', 'PLCB2']",0.9999871313821947,0,0,5
327,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.6387018072074451,0.9276100400145507,0.4158638965875899,"['IKBKB', 'GRB14', 'CHUK', 'BAD', 'RASA1', 'KRAS', 'NOS1', 'MAPK14', 'NCK1', 'MAPK3']",0.9999871313821947,0,0,10
328,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.646416492131003,0.9240406343798724,0.4031693318920091,"['YY1', 'ACLY', 'PRKAA1', 'SEC24A', 'GPAM', 'SAR1B', 'SCAP', 'PRKACA', 'LPIN1', 'ATF6', 'LDLR', 'KPNB1']",0.9999871313821947,0,0,12
329,7-oxo-C and 7beta-HC pathways WP5064,0.6542533870510373,0.9071183706392418,0.38485454844629413,"['ACOT9', 'DBP', 'SCP2', 'NPC1']",0.9999871313821947,0,0,4
330,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.6542533870510373,0.9071183706392418,0.38485454844629413,"['SMAD2', 'TGFB2', 'KRAS', 'TGFBR1']",0.9999871313821947,0,0,4
331,Amyotrophic lateral sclerosis (ALS) WP2447,0.6542586748580806,0.9070508939742503,0.38481858982102646,"['DAXX', 'PPP3CC', 'BAD', 'NEFL', 'NOS1', 'MAPK14']",0.9999871313821947,0,0,6
332,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.6542586748580806,0.9070508939742503,0.38481858982102646,"['LATS1', 'SGMS1', 'PAK6', 'PAK2', 'ACTB', 'MAP4K4']",0.9999871313821947,0,0,6
333,Neural Crest Cell Migration in Cancer WP4565,0.6542586748580806,0.9070508939742503,0.38481858982102646,"['NTRK2', 'TIAM1', 'KIDINS220', 'PIK3R4', 'PAK6', 'PAK2']",0.9999871313821947,0,0,6
334,Notch Signaling WP268,0.6542586748580806,0.9070508939742503,0.38481858982102646,"['APH1A', 'NCSTN', 'CTBP2', 'DVL1', 'NUMB', 'PSEN1']",0.9999871313821947,0,0,6
335,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.65793158526113,0.9069833191970597,0.37971249094425386,"['PPP1R16B', 'PPP1CC', 'PPP1R3F', 'EIF2AK1', 'PPP1R8', 'PPP1R12B', 'ATF6', 'PPP1R9B']",0.9999871313821947,0,0,8
336,DNA IR-damage and cellular response via ATR WP4016,0.660757959014634,0.9146721249717458,0.37901056651800935,"['SMARCAL1', 'UPF1', 'POLN', 'CEP164', 'H2AFX', 'RPA2', 'RAD52', 'HERC2', 'UIMC1', 'CHEK1', 'USP1', 'ATM', 'ATR']",0.9999871313821947,0,0,13
337,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.6656636700392632,1.0206671501087745,0.4153816612277233,['PPARA'],0.9999871313821947,0,0,1
338,Metastatic brain tumor WP2249,0.6656636700392632,1.0206671501087745,0.4153816612277233,['CDK6'],0.9999871313821947,0,0,1
339,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.6656636700392632,1.0206671501087745,0.4153816612277233,['HEY1'],0.9999871313821947,0,0,1
340,mir-124 predicted interactions with cell cycle and differentiation  WP3595,0.6656636700392632,1.0206671501087745,0.4153816612277233,['PRKAA1'],0.9999871313821947,0,0,1
341,Mitochondrial fatty acid synthesis pathway WP4317,0.6656636700392632,1.0206671501087745,0.4153816612277233,['MCAT'],0.9999871313821947,0,0,1
342,Small Ligand GPCRs WP247,0.6656636700392632,1.0206671501087745,0.4153816612277233,['S1PR3'],0.9999871313821947,0,0,1
343,Somatic sex determination WP4814,0.6656636700392632,1.0206671501087745,0.4153816612277233,['FGF9'],0.9999871313821947,0,0,1
344,Cysteine and methionine catabolism WP4504,0.6682809467588621,0.9071857494055535,0.36563814536864797,"['GCLC', 'AHCY']",0.9999871313821947,0,0,2
345,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.6682809467588621,0.9071857494055535,0.36563814536864797,"['MYRIP', 'SYTL3']",0.9999871313821947,0,0,2
346,GPR40 Pathway WP3958,0.6682809467588621,0.9071857494055535,0.36563814536864797,"['PLCB1', 'PLCB2']",0.9999871313821947,0,0,2
347,Mammalian disorder of sexual development WP4842,0.6682809467588621,0.9071857494055535,0.36563814536864797,"['RBFOX2', 'FGF9']",0.9999871313821947,0,0,2
348,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,0.6682809467588621,0.9071857494055535,0.36563814536864797,"['IL11RA', 'JAK1']",0.9999871313821947,0,0,2
349,RalA downstream regulated genes WP2290,0.6682809467588621,0.9071857494055535,0.36563814536864797,"['KRAS', 'EXOC2']",0.9999871313821947,0,0,2
350,PDGFR-beta pathway WP3972,0.6700294469328321,0.8873259448707019,0.3553151374887887,"['MAP2K1', 'MAP3K1', 'RASA1', 'JAK1', 'MAPK3']",0.9999871313821947,0,0,5
351,Prion disease pathway WP3995,0.6700294469328321,0.8873259448707019,0.3553151374887887,"['PRNP', 'RAD21', 'EP300', 'FYN', 'MAPK3']",0.9999871313821947,0,0,5
352,Tumor suppressor activity of SMARCB1 WP4204,0.6700294469328321,0.8873259448707019,0.3553151374887887,"['RB1', 'SMARCC1', 'CDK6', 'ARID1B', 'EZH2']",0.9999871313821947,0,0,5
353,Selenium Micronutrient Network WP15,0.6727183234301696,0.8958492239467849,0.35514023187857835,"['PRDX3', 'GPX3', 'RFK', 'SELENOP', 'PNPO', 'HBA1', 'SELENOT', 'SOD2', 'LDLR']",0.9999871313821947,0,0,9
354,Constitutive Androstane Receptor Pathway WP2875,0.6787147842478551,0.8747149077337757,0.33899951705235426,"['PTPA', 'HSP90AA1', 'NCOA6']",0.9999871313821947,0,0,3
355,Hippo-Yap signaling pathway WP4537,0.6787147842478551,0.8747149077337757,0.33899951705235426,"['LATS1', 'STK38L', 'MAP4K4']",0.9999871313821947,0,0,3
356,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.6787147842478551,0.8747149077337757,0.33899951705235426,"['EIF2S3', 'EIF3G', 'EIF3A']",0.9999871313821947,0,0,3
357,Hepatitis B infection WP4666,0.6853286204975758,0.9114045039864477,0.344380405609197,"['SMAD2', 'MAP2K1', 'TGFB2', 'MAP3K1', 'ATP6AP1', 'CHUK', 'DDX58', 'BAD', 'NFATC3', 'NFATC2', 'TYK2', 'MAPK14', 'TGFBR1', 'IKBKB', 'TBK1', 'EP300', 'TAB2', 'KRAS', 'MAP3K7', 'JAK1', 'MAPK3']",0.9999871313821947,0,0,21
358,Cannabinoid receptor signaling WP3869,0.6901988004163481,0.8592988824147483,0.3186070641571917,"['PRKAR1B', 'PRKACA', 'MAPK14', 'MAPK3']",0.9999871313821947,0,0,4
359,Gastric Cancer Network 2 WP2363,0.6901988004163481,0.8592988824147483,0.3186070641571917,"['AHCTF1', 'UBE2T', 'SNURF', 'LBR']",0.9999871313821947,0,0,4
360,Sleep regulation WP3591,0.6901988004163481,0.8592988824147483,0.3186070641571917,"['NLGN1', 'GRIN2A', 'AHCY', 'BTBD9']",0.9999871313821947,0,0,4
361,Thermogenesis WP4321,0.6912876886210308,0.9007502344482651,0.3325562706550569,"['SMARCC1', 'CPT1A', 'PRKAA1', 'FRS2', 'MAPK14', 'ARID1B', 'ACTB', 'ADCY5', 'RPTOR', 'RPS6KA3', 'RPS6KA6', 'AKT1S1', 'GNAS', 'PRKG2', 'KRAS', 'SLC25A20', 'PRKACA']",0.9999871313821947,0,0,17
362,MECP2 and Associated Rett Syndrome WP3584,0.6984810887920883,0.8800910466078716,0.3158181855352578,"['FGF5', 'RBFOX1', 'CNP', 'GPRIN1', 'FOXG1', 'TET3', 'SP3', 'NF1', 'TARDBP', 'GRIA3', 'EZH2']",0.9999871313821947,0,0,11
363,Vitamin D Receptor Pathway WP2877,0.7013465726417702,0.8840252488468074,0.3136107122079224,"['TGFB2', 'IGFBP3', 'CLEC16A', 'NFATC2', 'CDKAL1', 'MYO9B', 'STAM', 'ASAP2', 'ATP2B1', 'CDC34', 'BGLAP', 'TIMP2', 'SOSTDC1']",0.9999871313821947,0,0,13
364,Endometrial cancer WP4155,0.7083983309873959,0.868168695773318,0.29930005451883496,"['APC2', 'MAP2K1', 'PDPK1', 'BAD', 'ILK', 'KRAS', 'POLK', 'AXIN2', 'CTNNA2', 'MAPK3']",0.9999871313821947,0,0,10
365,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.7098825606867767,0.8743044360081127,0.29958542486009665,"['RPTOR', 'RPS6KA6', 'MAP2K1', 'THRB', 'BAD', 'AKT1S1', 'PRKG2', 'FRS2', 'SLC16A10', 'PRKACA', 'PLCB1', 'MAPK14']",0.9999871313821947,0,0,12
366,Cancer immunotherapy by PD-1 blockade WP4585,0.71591112568178,0.8163946318462096,0.27283847029413094,"['NFATC3', 'NFATC2']",0.9999871313821947,0,0,2
367,Cell Differentiation - Index expanded WP2023,0.71591112568178,0.8163946318462096,0.27283847029413094,"['RUNX2', 'EZH2']",0.9999871313821947,0,0,2
368,Major receptors targeted by epinephrine and norepinephrine WP4589,0.71591112568178,0.8163946318462096,0.27283847029413094,"['ADRA2C', 'ADCY5']",0.9999871313821947,0,0,2
369,Serotonin and anxiety WP3947,0.71591112568178,0.8163946318462096,0.27283847029413094,"['GABRA1', 'PLCD4']",0.9999871313821947,0,0,2
370,Immune response to tuberculosis WP4197,0.7174640887660105,0.8163280116110305,0.2710473350875257,"['TYK2', 'IFIT1', 'JAK1']",0.9999871313821947,0,0,3
371,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.7174640887660105,0.8163280116110305,0.2710473350875257,"['GALNT1', 'B3GALT1', 'SGPP2']",0.9999871313821947,0,0,3
372,Toll-like Receptor Signaling related to MyD88 WP3858,0.7174640887660105,0.8163280116110305,0.2710473350875257,"['IKBKB', 'TBK1', 'CHUK']",0.9999871313821947,0,0,3
373,TYROBP causal network in microglia WP3945,0.7174640887660105,0.8163280116110305,0.2710473350875257,"['RBM47', 'DPYD', 'TGFBR1']",0.9999871313821947,0,0,3
374,"GPCRs, Class A Rhodopsin-like WP455",0.7204929302885208,0.8694554224923287,0.28502459474170083,"['GPR27', 'GPR39', 'CHRM3', 'RABGAP1', 'CHRM1', 'HTR1E', 'CHRM5', 'GPR83', 'ADRA2C', 'SSTR3', 'LTB4R', 'GPR161', 'GPER1']",0.9999871313821947,0,0,13
375,Pre-implantation embryo WP3527,0.7234014449295912,0.8162613430127041,0.2642980455397081,"['KHSRP', 'CELF3', 'MTA3', 'HNRNPAB']",0.9999871313821947,0,0,4
376,AMP-activated protein kinase (AMPK) signaling WP1403,0.7296151344618456,0.850006062810719,0.26795429362055206,"['RPTOR', 'GYS1', 'CCNA1', 'CPT1A', 'PRKAA1', 'EEF2K', 'PIK3C3', 'PLCB1', 'ADIPOR1', 'EEF2']",0.9999871313821947,0,0,10
377,ACE Inhibitor Pathway WP554,0.7314669721607064,0.8164612037708484,0.2553100395707294,['ATP6AP2'],0.9999871313821947,0,0,1
378,Benzo(a)pyrene metabolism WP696,0.7314669721607064,0.8164612037708484,0.2553100395707294,['AKR1C2'],0.9999871313821947,0,0,1
379,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.7314669721607064,0.8164612037708484,0.2553100395707294,['SMAD5'],0.9999871313821947,0,0,1
380,EDA signaling in hair follicle development WP3930,0.7314669721607064,0.8164612037708484,0.2553100395707294,['SOSTDC1'],0.9999871313821947,0,0,1
381,Fluoroacetic acid toxicity WP4966,0.7314669721607064,0.8164612037708484,0.2553100395707294,['ALDH3A2'],0.9999871313821947,0,0,1
382,Nephrogenesis WP5052,0.7314669721607064,0.8164612037708484,0.2553100395707294,['MEIS1'],0.9999871313821947,0,0,1
383,Pilocytic astrocytoma WP2253,0.7314669721607064,0.8164612037708484,0.2553100395707294,['NF1'],0.9999871313821947,0,0,1
384,Selective expression of chemokine receptors during T-cell polarization WP4494,0.7314669721607064,0.8164612037708484,0.2553100395707294,['TGFB2'],0.9999871313821947,0,0,1
385,Serine Metabolism WP4688,0.7314669721607064,0.8164612037708484,0.2553100395707294,['PSPH'],0.9999871313821947,0,0,1
386,Serotonin Transporter Activity WP1455,0.7314669721607064,0.8164612037708484,0.2553100395707294,['NOS1'],0.9999871313821947,0,0,1
387,Kit receptor signaling pathway WP304,0.7320602200186039,0.8369916766863332,0.26105142703953915,"['RPS6KA3', 'MAP2K1', 'BAD', 'EP300', 'FYN', 'GAB2', 'MAPK14', 'MAPK3']",0.9999871313821947,0,0,8
388,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.7464450677088946,0.8160610465116279,0.23864338498359836,"['RB1', 'SMAD2', 'TGFB2', 'ICMT', 'DICER1', 'ACTB', 'RUNX2']",0.9999871313821947,0,0,7
389,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.7497852725026001,0.8325847618057772,0.2397581156875926,"['APC2', 'CDK6', 'CTBP2', 'CHD8', 'DVL1', 'AXIN2', 'ROR2', 'MAP3K7', 'LRP6', 'EZH2']",0.9999871313821947,0,0,10
390,Angiogenesis WP1539,0.7524785256752953,0.7652394775036284,0.21762096064511008,"['TIMP2', 'ARNT', 'MAPK14']",0.9999871313821947,0,0,3
391,Gastric Cancer Network 1 WP2361,0.7524785256752953,0.7652394775036284,0.21762096064511008,"['CCNA1', 'RNF216', 'CEP192']",0.9999871313821947,0,0,3
392,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.7524785256752953,0.7652394775036284,0.21762096064511008,"['BAD', 'MAPK14', 'MCL1']",0.9999871313821947,0,0,3
393,Mitochondrial Gene Expression WP391,0.7524785256752953,0.7652394775036284,0.21762096064511008,"['MTERF1', 'NRF1', 'HCFC1']",0.9999871313821947,0,0,3
394,Glycosylation and related congenital defects WP4521,0.7538795781320453,0.7773226168870452,0.21961123352455947,"['DPAGT1', 'TUSC3', 'PMM2', 'MGAT2']",0.9999871313821947,0,0,4
395,IL17 signaling pathway WP2112,0.7538795781320453,0.7773226168870452,0.21961123352455947,"['IKBKB', 'MAP3K7', 'JAK1', 'MAPK3']",0.9999871313821947,0,0,4
396,Tryptophan metabolism WP465,0.7538795781320453,0.7773226168870452,0.21961123352455947,"['ALDH3A2', 'TDO2', 'PRMT1', 'DHCR24']",0.9999871313821947,0,0,4
397,TP53 network WP1742,0.7576468969215031,0.7421109902067464,0.2059638790882972,"['ABL1', 'ATM']",0.9999871313821947,0,0,2
398,IL-2 signaling pathway WP49,0.7579289929411428,0.7847326964974024,0.2175008887214117,"['MAP2K1', 'FYN', 'GAB2', 'JAK1', 'MAPK3']",0.9999871313821947,0,0,5
399,Neural Crest Differentiation WP2064,0.761657135613879,0.8159272727272727,0.22214336206066207,"['CDH6', 'HDAC4', 'CTBP2', 'DVL1', 'AXIN2', 'HDAC8', 'HDAC9', 'SOX5', 'HDAC7']",0.9999871313821947,0,0,9
400,Apoptosis Modulation and Signaling WP1772,0.7758793317386602,0.8157933042212518,0.20701429855785075,"['IKBKB', 'PIDD1', 'DAXX', 'ENDOG', 'BAD', 'PEA15', 'CASP2', 'HTRA2', 'PRKD1', 'MCL1', 'MAPK3']",0.9999871313821947,0,0,11
401,Chemokine signaling pathway WP3929,0.7788835348558076,0.8436639031815723,0.21082633671681125,"['MAP2K1', 'CHUK', 'ROCK1', 'GNAI3', 'ARRB1', 'CX3CL1', 'GNG13', 'VAV2', 'ADCY5', 'GNAI2', 'TIAM2', 'IKBKB', 'TIAM1', 'GRK4', 'KRAS', 'PLCB1', 'PLCB2', 'MAPK3']",0.9999871313821947,0,0,18
402,Osteoblast differentiation WP4787,0.7801819714641244,0.8274860748132309,0.2054052876531249,"['PIK3R4', 'PIK3C2A', 'MAPK14', 'SMAD5', 'RUNX2', 'PIK3C2B', 'LRP6', 'FGF5', 'FGF9', 'HEY1', 'PIK3C3', 'PRKD1', 'BMPR1A', 'MAPK3']",0.9999871313821947,0,0,14
403,Oncostatin M Signaling Pathway WP2374,0.780977726703229,0.7981185770750988,0.19730181477753042,"['MAP2K1', 'JUND', 'LIFR', 'KRAS', 'TYK2', 'MAPK14', 'LDLR', 'JAK1', 'MAPK3']",0.9999871313821947,0,0,9
404,The influence of laminopathies on Wnt signaling WP4844,0.7816973164675819,0.7419237749546279,0.18272668282641977,"['ICMT', 'CDK6', 'DICER1', 'RUNX2']",0.9999871313821947,0,0,4
405,Target Of Rapamycin (TOR) Signaling WP1471,0.7829687717601117,0.7556012802926383,0.18486727299967223,"['RPTOR', 'PRKAA1', 'RRAGA', 'MAPKAP1', 'AKT1S1']",0.9999871313821947,0,0,5
406,1q21.1 copy number variation syndrome WP4905,0.7839107362791286,0.7201613591735678,0.17533057229259297,"['PRKAA1', 'ACP6', 'TJP2']",0.9999871313821947,0,0,3
407,EPO Receptor Signaling WP581,0.7839107362791286,0.7201613591735678,0.17533057229259297,"['MAP2K1', 'RASA1', 'MAPK3']",0.9999871313821947,0,0,3
408,Genes controlling nephrogenesis WP4823,0.7839107362791286,0.7201613591735678,0.17533057229259297,"['ILK', 'NCK1', 'CD2AP']",0.9999871313821947,0,0,3
409,SARS-CoV-2 mitochondrial interactions WP5038,0.7839107362791286,0.7201613591735678,0.17533057229259297,"['TBK1', 'DDX58', 'PHB2']",0.9999871313821947,0,0,3
410,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.7839107362791286,0.7201613591735678,0.17533057229259297,"['RASA1', 'NFATC2', 'FYN']",0.9999871313821947,0,0,3
411,Aspirin and miRNAs WP4707,0.7843227271643339,0.680323906212231,0.1652742851073692,['PPARA'],0.9999871313821947,0,0,1
412,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.7843227271643339,0.680323906212231,0.1652742851073692,['RUNX2'],0.9999871313821947,0,0,1
413,Disorders of the Krebs cycle WP4236,0.7843227271643339,0.680323906212231,0.1652742851073692,['PDHX'],0.9999871313821947,0,0,1
414,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.7843227271643339,0.680323906212231,0.1652742851073692,['JAK1'],0.9999871313821947,0,0,1
415,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.7843227271643339,0.680323906212231,0.1652742851073692,['ZEB2'],0.9999871313821947,0,0,1
416,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.7843227271643339,0.680323906212231,0.1652742851073692,['LDLR'],0.9999871313821947,0,0,1
417,Mevalonate pathway WP3963,0.7843227271643339,0.680323906212231,0.1652742851073692,['ACAT2'],0.9999871313821947,0,0,1
418,Osteoblast Signaling WP322,0.7843227271643339,0.680323906212231,0.1652742851073692,['BGLAP'],0.9999871313821947,0,0,1
419,Pentose Phosphate Metabolism WP134,0.7843227271643339,0.680323906212231,0.1652742851073692,['TKT'],0.9999871313821947,0,0,1
420,Sulfation Biotransformation Reaction WP692,0.7843227271643339,0.680323906212231,0.1652742851073692,['PAPSS2'],0.9999871313821947,0,0,1
421,Urea cycle and related diseases WP4571,0.7843227271643339,0.680323906212231,0.1652742851073692,['SLC25A13'],0.9999871313821947,0,0,1
422,Metapathway biotransformation Phase I and II WP702,0.7869167725514117,0.8266192577417067,0.19808507813290901,"['GSTM3', 'GLYATL2', 'NAA30', 'GPX3', 'GSTP1', 'AKR1C2', 'KCNAB1', 'HS6ST1', 'NAT14', 'HS6ST2', 'CHST11', 'CHST1', 'NAT8L', 'GAL3ST3', 'CHST2']",0.9999871313821947,0,0,15
423,NAD+ metabolism WP3644,0.7939631140244638,0.6802079555071938,0.1569364059336667,"['NMNAT3', 'SIRT2']",0.9999871313821947,0,0,2
424,Pyrimidine metabolism and related diseases WP4225,0.7939631140244638,0.6802079555071938,0.1569364059336667,"['RRM2B', 'DPYD']",0.9999871313821947,0,0,2
425,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.7939631140244638,0.6802079555071938,0.1569364059336667,"['BCL2L13', 'MCL1']",0.9999871313821947,0,0,2
426,Riboflavin and CoQ disorders WP5037,0.7939631140244638,0.6802079555071938,0.1569364059336667,"['RFK', 'ETFDH']",0.9999871313821947,0,0,2
427,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.7944117758201651,0.7769988402485676,0.17882888045129114,"['SMARCAL1', 'ILK', 'FYN', 'SYNPO', 'VCL', 'NCK1', 'CD2AP', 'LRP6']",0.9999871313821947,0,0,8
428,Gastrin signaling pathway WP4659,0.801229577190593,0.8155247813411078,0.1807266198199618,"['MAP2K1', 'CHUK', 'ROCK1', 'BAD', 'ARHGEF28', 'ARRB1', 'MAPK14', 'HDAC7', 'IKBKB', 'FYN', 'KRAS', 'PRKD1', 'PRKACA', 'LAMTOR3', 'MAPK3']",0.9999871313821947,0,0,15
429,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.8039770469389348,0.7843411590228615,0.17113112972545894,"['RB1', 'MAP2K1', 'PDPK1', 'GNAI3', 'GNAS', 'PLCB1', 'MAPK14', 'JAK1', 'GNAI2', 'MAPK3']",0.9999871313821947,0,0,10
430,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.8118127451352924,0.8627681406752933,0.17987471177457742,"['PFKFB4', 'PRKAA1', 'PHLPP1', 'CHRM1', 'CAB39L', 'PIK3R4', 'SLC2A1', 'PIK3C2A', 'PIK3C2B', 'RPTOR', 'IKBKB', 'PPP2CA', 'GYS1', 'PPP2R1B', 'FGF9', 'PPP2R1A', 'PDGFD', 'NOS1', 'PELO', 'EIF4E', 'JAK1', 'MAPK3', 'MAP2K1', 'HSP90AA1', 'PDPK1', 'BAD', 'VEGFD', 'PPP2R5D', 'PPP2R5C', 'PPP2R3A', 'GNG13', 'RAB11B', 'EFNA3', 'PPP2R2B', 'AKT1S1', 'KRAS']",0.9999871313821947,0,0,36
431,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.8119617072595194,0.6800919206579584,0.14166457423224316,"['PRKACA', 'MAPK14', 'MAPK3']",0.9999871313821947,0,0,3
432,Mitochondrial complex III assembly WP4921,0.8253759917508895,0.6278284646075724,0.12049048387511169,"['UQCC3', 'CYC1']",0.9999871313821947,0,0,2
433,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.8253759917508895,0.6278284646075724,0.12049048387511169,"['ACLY', 'PDHA1']",0.9999871313821947,0,0,2
434,Biomarkers for urea cycle disorders WP4583,0.8267777662379621,0.5830829793846473,0.11091366118228689,['GPT'],0.9999871313821947,0,0,1
435,Blood Clotting Cascade WP272,0.8267777662379621,0.5830829793846473,0.11091366118228689,['F8A1'],0.9999871313821947,0,0,1
436,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.8267777662379621,0.5830829793846473,0.11091366118228689,['ADH5'],0.9999871313821947,0,0,1
437,Heme Biosynthesis WP561,0.8267777662379621,0.5830829793846473,0.11091366118228689,['UROD'],0.9999871313821947,0,0,1
438,IL1 and megakaryocytes in obesity WP2865,0.8267777662379621,0.5830829793846473,0.11091366118228689,['TIMP2'],0.9999871313821947,0,0,1
439,DNA Replication WP466,0.8269582223352006,0.7033656374427165,0.13364024647795564,"['ORC5', 'PRIM2', 'DBF4', 'MCM3', 'RPA2']",0.9999871313821947,0,0,5
440,Wnt Signaling Pathway WP363,0.8275805006791085,0.732101595110316,0.1385494176644632,"['CDK6', 'DVL1', 'NFATC2', 'AXIN2', 'ROR2', 'MAP3K7', 'LRP6']",0.9999871313821947,0,0,7
441,mRNA Processing WP411,0.8326763307941412,0.8151205259313368,0.14925694023312921,"['SRPK2', 'SF3B4', 'RBM39', 'SF3B2', 'TMED10', 'RNGTT', 'PRMT1', 'SFSWAP', 'NONO', 'DICER1', 'SUPT5H', 'PRPF8', 'HNRNPAB', 'NUDT21', 'PRPF18', 'POLR2A', 'PRPF3', 'DHX15', 'CD2BP2', 'RBM5', 'SRSF9']",0.9999871313821947,0,0,21
442,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.8368629751344846,0.644240317775571,0.1147359352066165,"['RB1', 'CBX5', 'MTA3']",0.9999871313821947,0,0,3
443,Unfolded protein response WP4925,0.8368629751344846,0.644240317775571,0.1147359352066165,"['CASP2', 'ATF6', 'NFE2L2']",0.9999871313821947,0,0,3
444,Glioblastoma signaling pathways WP2261,0.8413617798261963,0.7644703312704769,0.13204966146683147,"['RB1', 'MAP2K1', 'CDK6', 'PDPK1', 'NF1', 'EP300', 'ATM', 'KRAS', 'PIK3C2A', 'MAP2K5', 'PIK3C2B', 'MAPK3']",0.9999871313821947,0,0,12
445,Wnt signaling WP428,0.8413617798261963,0.7644703312704769,0.13204966146683147,"['PPP3CC', 'CTBP2', 'CHD8', 'DVL1', 'NFATC3', 'NFATC2', 'ROR2', 'PLCB1', 'MAP3K7', 'PLCB2', 'CAMK2G', 'LRP6']",0.9999871313821947,0,0,12
446,p53 transcriptional gene network WP4963,0.8442965221186259,0.713735465116279,0.12080080989609074,"['PIDD1', 'RRM2B', 'ZMAT3', 'SLC2A1', 'POLK', 'ACAD11', 'CX3CL1']",0.9999871313821947,0,0,7
447,PPAR signaling pathway WP3942,0.8443945408193786,0.6992268174977946,0.11826402717823123,"['CPT1A', 'SCP2', 'PDPK1', 'ILK', 'SORBS1', 'PPARA']",0.9999871313821947,0,0,6
448,Kallmann's Syndrome WP5074,0.8524084637180606,0.5829317581221825,0.09308805156646471,"['GNRH1', 'FRS2']",0.9999871313821947,0,0,2
449,Pregnane X receptor pathway WP2876,0.8524084637180606,0.5829317581221825,0.09308805156646471,"['HSP90AA1', 'NCOA3']",0.9999871313821947,0,0,2
450,Pyrimidine metabolism WP4022,0.8539585181616279,0.7526420430679622,0.11882160133275393,"['PRIM2', 'PNPT1', 'UCK1', 'RRM2B', 'POLR2A', 'POLR3B', 'POLR2C', 'DPYD', 'ENPP1', 'CMPK2', 'POLR3G', 'DCK']",0.9999871313821947,0,0,12
451,Cancer immunotherapy by CTLA4 blockade WP4582,0.8608780955133895,0.5101522842639594,0.07642202091106534,['PPP2CA'],0.9999871313821947,0,0,1
452,Cytosine methylation WP3585,0.8608780955133895,0.5101522842639594,0.07642202091106534,['TET3'],0.9999871313821947,0,0,1
453,Genes targeted by miRNAs in adipocytes WP1992,0.8608780955133895,0.5101522842639594,0.07642202091106534,['HDAC4'],0.9999871313821947,0,0,1
454,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.8608780955133895,0.5101522842639594,0.07642202091106534,['MAPK3'],0.9999871313821947,0,0,1
455,Trans-sulfuration pathway WP2333,0.8608780955133895,0.5101522842639594,0.07642202091106534,['AHCY'],0.9999871313821947,0,0,1
456,Bladder cancer WP2828,0.8686910920245894,0.6275582856345107,0.08833993155440426,"['RB1', 'MAP2K1', 'RPS6KA5', 'KRAS']",0.9999871313821947,0,0,4
457,miRNA regulation of prostate cancer signaling pathways WP3981,0.8686910920245894,0.6275582856345107,0.08833993155440426,"['AR', 'MAP2K1', 'BAD', 'KRAS']",0.9999871313821947,0,0,4
458,Neural Crest Cell Migration during Development WP4564,0.8686910920245894,0.6275582856345107,0.08833993155440426,"['TIAM1', 'PIK3R4', 'PAK6', 'PAK2']",0.9999871313821947,0,0,4
459,MET in type 1 papillary renal cell carcinoma WP4205,0.8731733431146128,0.6940300238984664,0.09412517259010106,"['MAP2K1', 'BAD', 'RAPGEF1', 'PAK6', 'KRAS', 'STRN', 'PAK2', 'MAPK3']",0.9999871313821947,0,0,8
460,Proteasome Degradation WP183,0.8731733431146128,0.6940300238984664,0.09412517259010106,"['UCHL1', 'PSMD12', 'PSMB4', 'PSMC3', 'PSMD2', 'PSMD3', 'H2AFX', 'PSMD1']",0.9999871313821947,0,0,8
461,Nanomaterial induced apoptosis WP2507,0.8755675634427105,0.544021279168178,0.07229115731772176,"['ENDOG', 'HTRA2']",0.9999871313821947,0,0,2
462,Purine metabolism and related disorders WP4224,0.8755675634427105,0.544021279168178,0.07229115731772176,"['GRM5', 'RRM2B']",0.9999871313821947,0,0,2
463,Peptide GPCRs WP24,0.8782140959742631,0.5827804271200497,0.07568270440602667,"['TACR1', 'ACKR1', 'SSTR3']",0.9999871313821947,0,0,3
464,IL-5 signaling pathway WP127,0.8851002525143763,0.6042616118841164,0.07375276474168366,"['MAP2K1', 'KRAS', 'JAK1', 'MAPK3']",0.9999871313821947,0,0,4
465,Toll-like Receptor Signaling Pathway WP75,0.8855129314177776,0.6795104810371986,0.08262046873603686,"['IKBKB', 'MAP2K1', 'TBK1', 'CHUK', 'TAB2', 'MAPK14', 'MAP3K7', 'MAPK3']",0.9999871313821947,0,0,8
466,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.8860537387325444,0.7116921975000577,0.08609886880637772,"['MAP2K1', 'PDPK1', 'BAD', 'PDGFD', 'NF1', 'RRAS2', 'KRAS', 'NRG2', 'EIF4E', 'JAK1', 'MAPK3']",0.9999871313821947,0,0,11
467,Mitochondrial complex I assembly model OXPHOS system WP4324,0.8867348636643541,0.663762506760411,0.07979039638485821,"['NUBPL', 'NDUFAF7', 'NDUFAF4', 'NDUFS4', 'NDUFAF2', 'NDUFS2', 'NDUFAF3']",0.9999871313821947,0,0,7
468,Development and heterogeneity of the ILC family WP3893,0.8882673529982006,0.4534284102812022,0.05372333529719321,['BCL11B'],0.9999871313821947,0,0,1
469,Hedgehog Signaling Pathway Netpath WP47,0.8882673529982006,0.4534284102812022,0.05372333529719321,['ARNTL'],0.9999871313821947,0,0,1
470,ID signaling pathway WP53,0.8882673529982006,0.4534284102812022,0.05372333529719321,['RB1'],0.9999871313821947,0,0,1
471,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.8882673529982006,0.4534284102812022,0.05372333529719321,['TGFB2'],0.9999871313821947,0,0,1
472,Nanoparticle triggered regulated necrosis WP2513,0.8882673529982006,0.4534284102812022,0.05372333529719321,['FTL'],0.9999871313821947,0,0,1
473,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.8882673529982006,0.4534284102812022,0.05372333529719321,['DDX58'],0.9999871313821947,0,0,1
474,TCA cycle in senescence WP5050,0.8882673529982006,0.4534284102812022,0.05372333529719321,['PDHA1'],0.9999871313821947,0,0,1
475,Transcriptional cascade regulating adipogenesis WP4211,0.8882673529982006,0.4534284102812022,0.05372333529719321,['CEBPG'],0.9999871313821947,0,0,1
476,Lung fibrosis WP3624,0.8951687567040029,0.5562409288824384,0.06159980226166952,"['RTEL1', 'ELN', 'NFE2L2']",0.9999871313821947,0,0,3
477,Apoptosis Modulation by HSP70 WP384,0.895330440584965,0.509974610083424,0.0563840277892643,"['MAP3K1', 'CASP2']",0.9999871313821947,0,0,2
478,Globo Sphingolipid Metabolism WP1424,0.895330440584965,0.509974610083424,0.0563840277892643,"['GALNT2', 'ST6GALNAC6']",0.9999871313821947,0,0,2
479,"Relationship between inflammation, COX-2 and EGFR WP4483",0.895330440584965,0.509974610083424,0.0563840277892643,"['KRAS', 'MAPK3']",0.9999871313821947,0,0,2
480,AGE/RAGE pathway WP2324,0.8985298278152134,0.6486191860465116,0.06939925366833474,"['IKBKB', 'SMAD2', 'MAP2K1', 'CHUK', 'ROCK1', 'MAPK14', 'MAPK3']",0.9999871313821947,0,0,7
481,Signaling of Hepatocyte Growth Factor Receptor WP313,0.8996904247879751,0.5826289862587504,0.06158653322918854,"['MAP2K1', 'RASA1', 'RAPGEF1', 'MAPK3']",0.9999871313821947,0,0,4
482,Retinoblastoma gene in cancer WP2446,0.9053954405415815,0.6792773129622893,0.0675089431404382,"['RB1', 'CDK6', 'FAF1', 'CHEK1', 'MCM3', 'ABL1', 'RPA2', 'SKP2', 'DCK', 'CDC25B']",0.9999871313821947,0,0,10
483,Nanoparticle-mediated activation of receptor signaling WP2643,0.9099693334392948,0.5320092131002714,0.05019207912820248,"['MAP2K1', 'KRAS', 'MAPK14']",0.9999871313821947,0,0,3
484,Oxysterols derived from cholesterol WP4545,0.9099693334392948,0.5320092131002714,0.05019207912820248,"['ACOT9', 'DBP', 'SCP2']",0.9999871313821947,0,0,3
485,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.9102659151759359,0.40804931109499637,0.03836418728840226,['ENPP1'],0.9999871313821947,0,0,1
486,FOXA2 pathway WP5066,0.9102659151759359,0.40804931109499637,0.03836418728840226,['MLXIPL'],0.9999871313821947,0,0,1
487,GDNF/RET signaling axis WP4830,0.9102659151759359,0.40804931109499637,0.03836418728840226,['SPRY1'],0.9999871313821947,0,0,1
488,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.9102659151759359,0.40804931109499637,0.03836418728840226,['RB1'],0.9999871313821947,0,0,1
489,Leptin Insulin Overlap WP3935,0.9102659151759359,0.40804931109499637,0.03836418728840226,['PDPK1'],0.9999871313821947,0,0,1
490,PI3K-Akt signaling pathway WP4172,0.9117060350716183,0.7906180865006553,0.07308289443425196,"['PRKAA1', 'PHLPP1', 'CHRM1', 'FLT3', 'PPP2R2A', 'RPTOR', 'IKBKB', 'PPP2CA', 'FGF5', 'GYS1', 'PPP2R1B', 'FGF9', 'PPP2R1A', 'PDGFD', 'THEM4', 'EIF4E', 'JAK1', 'MCL1', 'MAPK3', 'NTRK2', 'MAP2K1', 'HSP90AA1', 'CHUK', 'PDPK1', 'BAD', 'VEGFD', 'PPP2R5D', 'PPP2R5C', 'PPP2R3A', 'GNG13', 'EFNA3', 'CDK6', 'PPP2R2B', 'KRAS']",0.9999871313821947,0,0,34
491,ErbB signaling pathway WP673,0.9138261566127669,0.6886693294092916,0.06205938583786875,"['MAP2K1', 'PDPK1', 'BAD', 'ABL1', 'PAK6', 'CBLB', 'KRAS', 'NRG2', 'PAK2', 'CAMK2G', 'NCK1', 'MAPK3']",0.9999871313821947,0,0,12
492,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.9190090090068807,0.620307760364004,0.05239079248595167,"['CACNG8', 'SGCD', 'CACNB4', 'ATP2A2', 'CTNNA2', 'CACNG2', 'ACTB']",0.9999871313821947,0,0,7
493,Prostaglandin Synthesis and Regulation WP98,0.9228462081833619,0.5097968069666183,0.040932951911629094,"['CBR1', 'AKR1C2', 'PTGFRN']",0.9999871313821947,0,0,3
494,Breast cancer pathway WP4262,0.9228745264005652,0.7083326728906782,0.05685219329494134,"['RB1', 'APC2', 'MAP2K1', 'NCOA3', 'AXIN2', 'LRP6', 'FGF5', 'CDK6', 'FGF9', 'HEY1', 'DVL1', 'ATM', 'KRAS', 'POLK', 'ATR', 'MAPK3']",0.9999871313821947,0,0,16
495,Non-small cell lung cancer WP4255,0.9235463822595164,0.6434641148325358,0.051177439749004065,"['RB1', 'EML4', 'MAP2K1', 'CDK6', 'BAD', 'RASSF5', 'KRAS', 'POLK', 'MAPK3']",0.9999871313821947,0,0,9
496,DNA Repair Pathways Full Network WP4946,0.9236359436046481,0.7137502161865446,0.05669837963243661,"['FANCM', 'H2AFX', 'RPA2', 'GTF2H1', 'TERF2', 'RAD54B', 'CUL4A', 'RAD52', 'MSH3', 'CHEK1', 'USP1', 'ATM', 'POLK', 'MNAT1', 'FAN1', 'ATR', 'CUL4B']",0.9999871313821947,0,0,17
497,Nephrotic syndrome WP4758,0.9240412247589116,0.5436902601330913,0.04295076546726886,"['SMARCAL1', 'PMM2', 'SYNPO', 'CD2AP']",0.9999871313821947,0,0,4
498,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.9272756947284464,0.5662470749616719,0.042754118645766157,"['RB1', 'HSP90AA1', 'MAPK14', 'MCL1', 'NFE2L2']",0.9999871313821947,0,0,5
499,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.9279344556548333,0.37092095721537344,0.02774272823611018,['DKK3'],0.9999871313821947,0,0,1
500,Notch Signaling Pathway Netpath WP61,0.9313834824345854,0.5823257744797883,0.041394151754291356,"['APH1A', 'NCSTN', 'HEY1', 'NUMB', 'EP300', 'PSEN1']",0.9999871313821947,0,0,6
501,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.9340147458361052,0.48936139332365747,0.03340530275054565,"['SMAD2', 'NOS1', 'TGFBR1']",0.9999871313821947,0,0,3
502,Fatty Acid Biosynthesis WP357,0.9384281116715583,0.429337762251112,0.02728399621564378,"['ACLY', 'ECH1']",0.9999871313821947,0,0,2
503,Type II interferon signaling (IFNG) WP619,0.9384281116715583,0.429337762251112,0.02728399621564378,"['IRF2', 'JAK1']",0.9999871313821947,0,0,2
504,White fat cell differentiation WP4149,0.9384281116715583,0.429337762251112,0.02728399621564378,"['RARA', 'ZNF423']",0.9999871313821947,0,0,2
505,ESC Pluripotency Pathways WP3931,0.9410361381155004,0.6517073170731708,0.0396066885581022,"['FGF5', 'ACVR1', 'MAP2K1', 'FGF9', 'SELENOP', 'DVL1', 'LIFR', 'SMAD5', 'MAP2K5', 'BMPR1A', 'JAK1', 'LRP6']",0.9999871313821947,0,0,12
506,Omega-3/Omega-6 FA synthesis WP4723,0.9421250108284529,0.3399806623156877,0.020268730949820908,['PLA2G4B'],0.9999871313821947,0,0,1
507,Omega-9 FA synthesis WP4724,0.9421250108284529,0.3399806623156877,0.020268730949820908,['ELOVL6'],0.9999871313821947,0,0,1
508,Copper homeostasis WP3286,0.9442523922639257,0.536349042540993,0.030765937865615104,"['PRNP', 'MTF2', 'ADAM10', 'ADAM9', 'MT3']",0.9999871313821947,0,0,5
509,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.9466009089267481,0.5557573556120595,0.030498686161525946,"['PPP2CA', 'MAP2K1', 'DVL1', 'NEFL', 'NOS1', 'NCK1']",0.9999871313821947,0,0,6
510,Physiological and pathological hypertrophy of the heart WP1528,0.9485845717240665,0.4078346028291621,0.02152727623250629,"['LIFR', 'MAPK14']",0.9999871313821947,0,0,2
511,Nucleotide Excision Repair WP4753,0.9513199273228391,0.5225499506545258,0.0260777829271883,"['CUL4A', 'RPA2', 'GTF2H1', 'MNAT1', 'CUL4B']",0.9999871313821947,0,0,5
512,Eicosanoid Synthesis WP167,0.9535220073434563,0.31380041278518434,0.014934632006631943,['PLA2G4B'],0.9999871313821947,0,0,1
513,Corticotropin-releasing hormone signaling pathway WP2355,0.9555979060825481,0.5913079178885631,0.026856055382815568,"['GNAZ', 'HSP90AA1', 'MAP2K1', 'JUND', 'GNAS', 'ARRB1', 'MAPK14', 'GNAI2', 'MAPK3']",0.9999871313821947,0,0,9
514,Wnt signaling in kidney disease WP4150,0.9571294733348596,0.3883793633521599,0.01701746548005757,"['DVL1', 'LRP6']",0.9999871313821947,0,0,2
515,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.9575626001433101,0.509440813362382,0.022091483804840443,"['GCLC', 'JUND', 'ABL1', 'PAK2', 'HSPD1']",0.9999871313821947,0,0,5
516,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.9587163107305177,0.5314992340371768,0.022408042605601277,"['CTBP2', 'CHD8', 'DVL1', 'ROR2', 'LRP6', 'EZH2']",0.9999871313821947,0,0,6
517,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.9662409047167386,0.6262014852178787,0.021505069075905048,"['SMAD2', 'MAP2K1', 'TGFB2', 'TUSC3', 'NUBPL', 'NR2C2', 'MAPK14', 'TGFBR1', 'LRP6', 'ZEB2', 'CLDN12', 'KRAS', 'EZH2', 'MAPK3']",0.9999871313821947,0,0,14
518,Apoptosis WP254,0.9692227058560372,0.5280334840654608,0.016506782348596438,"['IKBKB', 'MAP3K1', 'CHUK', 'BAD', 'IRF2', 'CASP2', 'MCL1']",0.9999871313821947,0,0,7
519,Statin inhibition of cholesterol production WP430,0.9700262740817484,0.271912013536379,0.008274859343335939,['LDLR'],0.9999871313821947,0,0,1
520,Transcription factor regulation in adipogenesis WP3599,0.9700262740817484,0.271912013536379,0.008274859343335939,['LPIN1'],0.9999871313821947,0,0,1
521,Fluoropyrimidine Activity WP1601,0.9703152189281498,0.35454416426172114,0.01068393748202817,"['UCK1', 'DPYD']",0.9999871313821947,0,0,2
522,Allograft Rejection WP2328,0.9705975946085718,0.40761973875181423,0.012164726410366746,"['TUBA1B', 'C5', 'LRRK2']",0.9999871313821947,0,0,3
523,Oxidation by Cytochrome P450 WP43,0.9753439946264134,0.3397412646596542,0.008481659428466085,"['CYB5B', 'POR']",0.9999871313821947,0,0,2
524,Alpha 6 Beta 4 signaling pathway WP244,0.979543770901832,0.32612259702575264,0.006740417808094862,"['MAPK14', 'MAPK3']",0.9999871313821947,0,0,2
525,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.9806709597664427,0.23987970822846905,0.0046820414134532825,['IDH3G'],0.9999871313821947,0,0,1
526,Focal Adhesion WP306,0.9809832795272307,0.6352683461117196,0.012197065770571829,"['MAP2K1', 'ROCK1', 'PDPK1', 'BAD', 'TNK2', 'ILK', 'VEGFD', 'ACTB', 'VAV2', 'PPP1CC', 'PDGFD', 'RAPGEF1', 'CAPN2', 'PAK6', 'FLNB', 'FYN', 'PPP1R12B', 'PAK2', 'VCL', 'MAPK3']",0.9999871313821947,0,0,20
527,Oxidative phosphorylation WP623,0.9819587263708267,0.4427552019197373,0.008060801951413043,"['ATP6AP1', 'NDUFS7', 'ATP6AP2', 'NDUFS4', 'NDUFS2']",0.9999871313821947,0,0,5
528,Adipogenesis WP236,0.9822213633212542,0.5526488400093447,0.009913732739079974,"['RB1', 'BSCL2', 'WWTR1', 'BMP3', 'DVL1', 'NR2F1', 'RARA', 'LIFR', 'MIF', 'PPARA', 'LPIN1']",0.9999871313821947,0,0,11
529,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.9844783704562468,0.22653291435017323,0.003543733943043056,['RUNX2'],0.9999871313821947,0,0,1
530,Nucleotide metabolism WP404,0.9844783704562468,0.22653291435017323,0.003543733943043056,['RRM2B'],0.9999871313821947,0,0,1
531,Ovarian infertility WP34,0.9844783704562468,0.22653291435017323,0.003543733943043056,['ATM'],0.9999871313821947,0,0,1
532,Striated Muscle Contraction Pathway WP383,0.9844783704562468,0.22653291435017323,0.003543733943043056,['TMOD1'],0.9999871313821947,0,0,1
533,Vitamin A and carotenoid metabolism WP716,0.9859623694448835,0.3019116323432609,0.004268151909728125,"['RARA', 'BCO2']",0.9999871313821947,0,0,2
534,Differentiation Pathway WP2848,0.9899912609009067,0.20384336475707035,0.0020504936866362947,['TF'],0.9999871313821947,0,0,1
535,DNA Mismatch Repair WP531,0.991962955367652,0.19411927207431195,0.0015664485280272127,['RPA2'],0.9999871313821947,0,0,1
536,Mitochondrial CIV Assembly WP4922,0.9920742497977363,0.2716479264901463,0.002161591084360971,"['CMC1', 'COX5A']",0.9999871313821947,0,0,2
537,Melatonin metabolism and effects WP3298,0.9982692774402907,0.14549880866052003,0.0002520362359262383,['ARNTL'],0.9999871313821947,0,0,1
538,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.9988718510254345,0.20355458832063839,0.00022976953159586921,"['DHCR24', 'LBR']",0.9999871313821947,0,0,2
539,Small cell lung cancer WP4658,0.9998279099499825,0.2708545146453643,4.6615378109215365e-05,"['RB1', 'IKBKB', 'CDK6', 'CHUK', 'POLK']",0.9999871313821947,0,0,5
540,Nonalcoholic fatty liver disease WP4396,0.9998533043281066,0.37810549428860435,5.547050827247785e-05,"['IKBKB', 'VMP1', 'MLXIPL', 'PRKAA1', 'NDUFS7', 'NDUFS4', 'NDUFS2', 'CYC1', 'ADIPOR1', 'PPARA', 'COX5A']",0.9999871313821947,0,0,11
541,Cytoplasmic Ribosomal Proteins WP477,0.9999871313821947,0.19558743139527257,2.516956097044195e-06,"['RPS6KA3', 'RPS6KA6', 'RPLP0', 'RPS11']",0.9999871313821947,0,0,4
542,Electron Transport Chain (OXPHOS system in mitochondria) WP111,0.9999871313821947,0.19558743139527257,2.516956097044195e-06,"['NDUFS7', 'NDUFS4', 'NDUFS2', 'COX5A']",0.9999871313821947,0,0,4
